Document:

EX-4.3

 

EXHIBIT
4.3

SYNACOR, INC.

THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT

OCTOBER 19, 2006

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	 	 	 	 	Page
	1.
	 	Registration Rights	 	 	2	 
	 
	 	1.1               Definitions	 	 	2	 
	 
	 	1.2               Request for Registration	 	 	3	 
	 
	 	1.3               Company Registration	 	 	5	 
	 
	 	1.4               Form S-3 Registration	 	 	6	 
	 
	 	1.5               Obligations of the Company	 	 	7	 
	 
	 	1.6               Information from Holder	 	 	9	 
	 
	 	1.7               Expenses of Registration	 	 	9	 
	 
	 	1.8               Delay of Registration	 	 	10	 
	 
	 	1.9               Indemnification	 	 	10	 
	 
	 	1.10              Reports Under the 1934 Act	 	 	12	 
	 
	 	1.11              Assignment of Registration Rights	 	 	12	 
	 
	 	1.12              Limitations on Subsequent Registration Rights	 	 	13	 
	 
	 	1.13              “Market Stand-Off” Agreement	 	 	13	 
	 
	 	1.14              Termination of Registration Rights	 	 	14	 
	 
	 	 	 	 	 	 
	2.
	 	Covenants of the Company	 	 	14	 
	 
	 	2.1               Delivery of Financial Statements	 	 	14	 
	 
	 	2.2               Inspection	 	 	15	 
	 
	 	2.3               Termination of Information and Inspection Covenants	 	 	15	 
	 
	 	2.4               Right of First Offer	 	 	15	 
	 
	 	2.5               Key-Man Insurance	 	 	17	 
	 
	 	2.6               Directors and Officers Insurance	 	 	17	 
	 
	 	2.7               Meetings of the Board of Directors	 	 	17	 
	 
	 	2.8               Composition of Board Committees	 	 	17	 
	 
	 	2.9               Confidentiality Agreement	 	 	17	 
	 
	 	2.10              Termination of Certain Covenants	 	 	17	 
	 
	 	2.11              New Issuance and Liquidation Event	 	 	18	 
	 
	 	 	 	 	 	 
	3.
	 	Miscellaneous	 	 	18	 
	 
	 	3.1               Successors and Assigns	 	 	18	 
	 
	 	3.2               Governing Law	 	 	18	 
	 
	 	3.3               Counterparts	 	 	18	 
	 
	 	3.4               Titles and Subtitles	 	 	18	 
	 
	 	3.5               Notices	 	 	18	 
	 
	 	3.6               Expenses	 	 	19	 
	 
	 	3.7               Entire Agreement; Amendments and Waivers	 	 	19	 
	 
	 	3.8               Severability	 	 	19	 
	 
	 	3.9               Aggregation of Stock	 	 	19	 
	 
	 	3.10              Binding Effect	 	 	19	 
	 
	 	3.11              Additional Investors	 	 	20	 
	 
	 	3.12              Arbitration	 	 	20	 
	 
	 	3.13              Termination of Prior Agreement	 	 	20	 

i 

 

	 	 	 	 	 	 	 
	 	 	 	 	Page
	 
	 	3.14              Waiver of Right of First Refusal	 	 	20	 
	 
	 	3.15              Consent of Intel Capital	 	 	20	 

ii 

 

THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT

THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of
the 19th day of October, 2006, by and among Synacor, Inc., a Delaware corporation (the
“Company”), the holders of Series C Preferred Stock of the Company (the “Series C
Preferred Stock”) listed on the Schedule of Series C Investors attached as Schedule A
hereto (the “Series C Investors”), the holders of Series B Preferred Stock of the Company
(the “Series B Preferred Stock”) listed on the Schedule of Series B Investors attached as
Schedule B hereto (the “Series B Investors”), the holders of Series A-1 Preferred
Stock of the Company (the “Series A-1 Preferred Stock”) listed on the Schedule of Series
A-1 Investors attached as Schedule C hereto (the “Series A-1 Investors”), the
holders of Series A Preferred Stock of the Company (the “Series A Preferred Stock” and,
together with the Series C Preferred Stock, the Series B Preferred Stock and the Series A-1
Preferred Stock, the “Preferred Stock”) listed on the Schedule of Series A Investors
attached as Schedule D hereto (the “Series A Investors” and, together with the
Series C Investors, the Series B Investors and the Series A-1 Investors, the “Investors”),
the holders of Common Stock listed on Schedule E hereto, each of which is herein referred
to as a “Common Holder” and the lenders of the Company listed on Schedule F hereto,
each of which is herein referred to as a “Lender.” The Company, the Investors, the Common
Holders and the Lenders are individually each referred to herein as a “Party” and are
collectively referred to herein as the “Parties.”

RECITALS

          WHEREAS, the Company and the Series C Investors have entered into that certain Series C
Preferred Stock Purchase Agreement of even date herewith (the “Series C Agreement”) which
provides for, among other things, the purchase by the Series C Investors of shares of Series C
Preferred Stock;

          WHEREAS, in order to induce the Series C Investors to purchase Series C Preferred Stock and
invest funds in the Company pursuant to the Series C Agreement, the Investors, the Common Holders,
the Lenders and the Company hereby agree that this Agreement shall govern the rights of the
Investors, the Common Holders and the Lenders to cause the Company to register shares of Common
Stock issued or issuable to them and certain other matters as set forth herein;

          WHEREAS, the Company, certain of the Investors, the Common Holders and the Lenders are parties
to that certain Second Amended and Restated Investors’ Rights Agreement dated as of October 1, 2004
(the “Prior Agreement”);

          WHEREAS, Section 3.7 of the Prior Agreement provides (i) generally that the Prior Agreement
may be amended, and any provision therein waived, with the consent of the Company and the holders
of a majority of the Registrable Securities (as such term is defined in the Prior Agreement),
provided that such majority shall include Intel Capital (as defined therein); (ii) that the Prior
Agreement may be amended, and any provision therein waived, with the written consent of the holders
of a majority in interest of the Common Holders and Lenders if such amendment or waiver adversely
affects the obligations and/or rights of the Common

1

 

Holders and/or Lenders; (iii) that the provisions of Section 2.1 and 2.3 of the Prior
Agreement may be waived only with the written consent of the Company and the holders of a majority
of the Registrable Securities that are held by the qualifying Investors and Lenders and (iv) that
the provisions of Section 2.4 of the Prior Agreement may be amended or waived only with the written
consent of the Company and the holders of a majority of the Registrable Securities held by the
Major Investors;

          WHEREAS, the parties to the Prior Agreement necessary to amend the Prior Agreement have
resolved to do so, and such parties hereby agree that this Agreement shall amend and restate the
Prior Agreement in its entirety and to accept the rights created pursuant hereto in lieu of the
rights created under the Prior Agreement;

          NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein, the
Parties hereby agree that the Prior Agreement shall be superseded and replaced in its entirety by
this Agreement, and the Parties hereto further agree as follows:

          1. Registration Rights. The Company covenants and agrees as follows:

               1.1 Definitions. For purposes of this Section 1:

                    (a) The term “Act” means the Securities Act of 1933, as amended.

                    (b) The term “Form S-3” means such form under the Act as in effect on the date hereof
or any registration form under the Act subsequently adopted by the SEC that permits inclusion or
incorporation of substantial information by reference to other documents filed by the Company with
the SEC.

                    (c) The term “Holder” means any person owning or having the right to acquire
Registrable Securities or any assignee thereof in accordance with Section 1.11 hereof;
provided, however, that the Common Holders and Lenders shall not be deemed to be
Holders for purposes of Sections 1.2, 1.4, 1.12 (except to the extent that Section 1.12 relates to
a registration under Section 1.3 hereof) and 3.7.

                    (d) The term “Initial Offering” means the Company’s first firm commitment underwritten
public offering of its Common Stock under the Act.

                    (e) The term “1934 Act” means the Securities Exchange Act of 1934, as amended.

                    (f) The terms “register,” “registered,” and “registration” refer to a
registration effected by preparing and filing a registration statement or similar document in
compliance with the Act, and the declaration or ordering of effectiveness of such registration
statement or document.

                    (g) The term “Registrable Securities” means (i) the shares of Common Stock issuable or
issued upon conversion of the Preferred Stock, (ii) the shares of Common Stock issued to the Common
Holders or Investors; provided, however, that such shares

2

 

of Common Stock shall not
be deemed Registrable Securities for the purposes of Sections 1.2, 1.4, 1.12 (except to the extent
that Section 1.12 relates to a registration under Section 1.3 hereof) and 3.7, (iii) the shares of
Common Stock issued to the Lenders upon the exercise of warrants (the “Lender Warrants”)
issued pursuant to that certain Note and Warrant Purchase Agreement, dated as of November 18, 2002,
by and among the Company and the Lenders (the “Lenders Agreement”); provided,
however, that such shares of Common Stock shall not be deemed Registrable Securities for
the purposes of Sections 1.2, 1.4, 1.12 (except to the extent that Section 1.12 relates to a
registration under Section 1.3 hereof) and 3.7 and (iv) any Common Stock of the Company issued as
(or issuable upon the conversion or exercise of any warrant, right or other security that is issued
as) a dividend or other distribution with respect to, or in exchange for, or in replacement of, the
shares referenced in (i), (ii) and (iii) above, excluding in all cases, however, any Registrable
Securities sold by a person in a transaction in which his rights under this Section 1 are not
assigned.

                    (h) The number of shares of “Registrable Securities” outstanding shall be determined
by the number of shares of Common Stock outstanding that are, and the number of shares of Common
Stock issuable pursuant to then exercisable or convertible securities that are, Registrable
Securities.

                    (i) The term “Rule 144” shall mean Rule 144 under the Act.

                    (j) The term “Rule 144(k)” shall mean subsection (k) of Rule 144 under the Act.

                    (k) The term “SEC” shall mean the Securities and Exchange Commission.

               1.2 Request for Registration.

                    (a) Subject to the conditions of this Section 1.2, if the Company shall receive at any time
after the earlier of (i) January 31, 2009 or (ii) six (6) months after the effective date of the
Initial Offering, a written request from the Holders of thirty-five percent (35%) or more of the
Registrable Securities then outstanding (for purposes of this Section 1.2, the “Initiating
Holders”) that the Company file a registration statement under the Act covering the
registration of Registrable Securities with an anticipated aggregate offering price of at least
$10,000,000, then the Company shall, within twenty (20) days of the receipt thereof, give written
notice of such request to all Holders, and subject to the limitations of this Section 1.2, use all
commercially reasonable efforts to effect, as soon as practicable, the registration under the Act
of all Registrable Securities that the Holders request to be registered in a written request
received by the Company within twenty (20) days of the mailing of the Company’s notice pursuant to
this Section 1.2(a).

                    (b) If the Initiating Holders intend to distribute the Registrable Securities covered by their
request by means of an underwriting, they shall so advise the Company as a part of their request
made pursuant to this Section 1.2 and the Company shall include such information in the written
notice referred to in Section 1.2(a). In such event the right of any Holder to include its
Registrable Securities in such registration shall be conditioned

3

 

upon such Holder’s participation
in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting
(unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such
Holder) to the extent provided herein. All Holders proposing to distribute their securities
through such underwriting shall enter into an underwriting agreement in customary form with the
underwriter or underwriters selected for such underwriting by the Company (which underwriter or
underwriters shall be reasonably acceptable to a majority in interest of the Initiating Holders).
Notwithstanding any other provision of this Section 1.2, if the underwriter advises the Company
that marketing factors require a limitation on the number of securities underwritten (including
Registrable Securities), then the Company shall so advise all Holders of Registrable Securities
that would otherwise be underwritten pursuant hereto, and the number of shares that may be included
in the underwriting shall be allocated to the Holders of such Registrable Securities on a pro rata
basis based on the number of Registrable Securities held by all such Holders (including the
Initiating Holders). In no event shall any Registrable Securities be excluded from such
underwriting unless all other securities are first excluded. Any Registrable Securities excluded
or withdrawn from such underwriting shall be withdrawn from the registration.

                    (c) The Company shall not be required to effect a registration pursuant to this Section 1.2:

                         (i) in any particular jurisdiction in which the Company would be required to execute a general
consent to service of process in effecting such registration, unless the Company is already subject
to service in such jurisdiction and except as may be required under the Act; or

                         (ii) after the Company has effected two (2) registrations pursuant to this Section 1.2, and
such registrations have been declared or ordered effective; or

                         (iii) during the period starting with the date sixty (60) days prior to the Company’s good
faith estimate of the date of the filing of, and ending on a date one hundred eighty (180) days
following the effective date of, a Company-initiated registration subject to Section 1.3 below,
provided that the Company is actively employing in good faith all commercially reasonable efforts
to cause such registration statement to become effective; or

                         (iv) if the Initiating Holders propose to dispose of Registrable Securities that may be
registered on Form S-3 pursuant to Section 1.4 hereof; or

                         (v) if the Company shall furnish to Holders requesting a registration statement pursuant to
this Section 1.2, a certificate signed by the Company’s Chief Executive Officer or Chairman of the
Board stating that in the good faith judgment of the Board of Directors of the Company (the
“Board”), it would be seriously detrimental to the Company and its stockholders for such
registration statement to be effected at such time, in which event the
Company shall have the right to defer such filing for a period of not more than one hundred
twenty (120) days after receipt of the request of the Initiating Holders, provided that such right
shall be exercised by the Company not more than once in any twelve (12)-month period.

4

 

               1.3 Company Registration.

                    (a) If (but without any obligation to do so) the Company proposes to register (including for
this purpose a registration effected by the Company pursuant to Sections 1.2 or 1.4 hereof or for
stockholders other than the Holders) any of its stock or other securities under the Act in
connection with the public offering of such securities (other than a registration relating solely
to the sale of securities of participants in a Company stock plan, a registration relating to a
corporate reorganization or transaction under Rule 145 of the Act, a registration on any form that
does not include substantially the same information as would be required to be included in a
registration statement covering the sale of the Registrable Securities, or a registration in which
the only Common Stock being registered is Common Stock issuable upon conversion of debt securities
that are also being registered), the Company shall, at such time, promptly give each Holder written
notice of such registration. Upon the written request of each Holder given within twenty (20) days
after mailing of such notice by the Company in accordance with Section 3.5 hereof, the Company
shall, subject to the provisions of Section 1.3(c), use all commercially reasonable efforts to
cause to be registered under the Act all of the Registrable Securities that each such Holder has
requested to be registered.

                    (b) Right to Terminate Registration. The Company shall have the right to terminate or
withdraw any registration initiated by it under this Section 1.3 prior to the effectiveness of such
registration whether or not any Holder has elected to include securities in such registration. The
expenses of such withdrawn registration shall be borne by the Company in accordance with Section
1.7 hereof.

                    (c) Underwriting Requirements. In connection with any offering involving an
underwriting of shares of the Company’s capital stock, the Company shall not be required under this
Section 1.3 to include any of the Holders’ securities in such underwriting unless they accept the
terms of the underwriting as agreed upon between the Company and the underwriters selected by it
(or by other persons entitled to select the underwriters) and enter into an underwriting agreement
in customary form with such underwriters, and then only in such quantity as the underwriters
determine in their sole discretion will not jeopardize the success of the offering by the Company.
If the total amount of securities, including Registrable Securities, requested by stockholders to
be included in such offering exceeds the amount of securities sold other than by the Company that
the underwriters determine in their sole discretion is compatible with the success of the offering,
then the Company shall be required to include in the offering only that number of such securities,
including Registrable Securities, that the underwriters determine in their sole discretion will not
jeopardize the success of the offering. In no event shall any shares of Common Stock issuable or
issued upon conversion of the Preferred Stock be excluded from such offering unless all other
stockholders’ securities are first excluded. In the event that the underwriters determine that
less than all of the Registrable Securities requested to be registered can be included in such
offering, then the
Registrable Securities that are included in such offering shall be apportioned pro rata among
the selling Holders based on the number of Registrable Securities held by all selling Holders or in
such other proportions as shall mutually be agreed to by all such selling Holders. Notwithstanding
the foregoing, in no event shall (i) the amount of securities of the selling Holders included in
the offering be reduced below twenty-five percent (25%) of the total amount of securities included
in such offering, unless such offering is the initial public offering of the

5

 

Company’s securities,
in which case the selling Holders may be excluded if the underwriters make the determination
described above and no other stockholder’s securities are included or (ii) any securities held by a
Common Holder or a Lender be included in such offering if any Registrable Securities held by any
Investor (and that such Investor has requested to be registered) are excluded from such offering.
For purposes of the preceding sentence concerning apportionment, for any selling stockholder that
is a Holder of Registrable Securities and that is a venture capital fund, partnership or
corporation, the Affiliated venture capital funds, partners, retired partners and stockholders of
such Holder, or the estates and family members of any such partners and retired partners and any
trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling
Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the
aggregate amount of Registrable Securities owned by all such related entities and individuals.

               1.4 Form S-3 Registration. In case the Company shall receive from the Holders of at
least five percent (5%) of the Registrable Securities (for purposes of this Section 1.4, the
“Initiating Holders”) a written request or requests that the Company effect a registration
on Form S-3 and any related qualification or compliance with respect to all or a part of the
Registrable Securities owned by such Holder or Holders, the Company shall:

                    (a) within ten (10) days of the receipt thereof, give written notice of the proposed
registration, and any related qualification or compliance, to all other Holders; and

                    (b) use all commercially reasonable efforts to effect, as soon as practicable, such
registration and all such qualifications and compliances as may be so requested and as would permit
or facilitate the sale and distribution of all or such portion of such Holders’ Registrable
Securities as are specified in such request, together with all or such portion of the Registrable
Securities of any other Holders joining in such request as are specified in a written request given
within fifteen (15) days after receipt of such written notice from the Company, provided, however,
that the Company shall not be obligated to effect any such registration, qualification or
compliance, pursuant to this section 1.4:

                         (i) if Form S-3 is not available for such offering by the Holders;

                         (ii) if the Holders, together with the holders of any other securities of the Company entitled
to inclusion in such registration, propose to sell Registrable Securities and such other securities
(if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of
less than $5,000,000;

                         (iii) if the Company shall furnish to Holders requesting a registration statement pursuant to
this Section 1.4, a certificate signed by the Company’s Chief Executive Officer or Chairman of the
Board stating that in the good faith judgment of the Board, it would be seriously detrimental to
the Company and its stockholders for such registration statement to be effected at such time, in
which event the Company shall have the right to defer such filing for a period of not more than one
hundred twenty (120) days after receipt of the

6

 

request of the Initiating Holders, provided that
such right shall be exercised by the Company not more than once in any twelve (12)-month period;

                         (iv) during the period beginning sixty (60) days prior to the Company’s good faith estimate of
the date of the filing of, and ending on a date one hundred eighty (180) days following the
effective date of, a Company-initiated registration statement, provided that the Company is
actively employing in good faith all commercially reasonable efforts to cause such registration
statement to become effective;

                         (v) if the Company has, within the six (6) month period preceding the date of such request,
already effected the Initial Offering or one (1) registration on Form S-3 for the Holders pursuant
to this Section 1.4; or

                         (vi) in any particular jurisdiction in which the Company would be required to qualify to do
business or to execute a general consent to service of process in effecting such registration,
qualification or compliance.

                    (c) If the Initiating Holders intend to distribute the Registrable Securities covered by their
request by means of an underwriting, they shall so advise the Company as a part of their request
made pursuant to this Section 1.4 and the Company shall include such information in the written
notice referred to in Section 1.4(a). The provisions of Section 1.2(b) shall be applicable to such
request (with the substitution of Section 1.4 for references to Section 1.2).

                    (d) Subject to the foregoing, the Company shall file a registration statement covering the
Registrable Securities and other securities so requested to be registered as soon as practicable
after receipt of the request or requests of the Initiating Holders. Registrations effected
pursuant to this Section 1.4 shall not be counted as requests for registration effected pursuant to
Sections 1.2.

               1.5 Obligations of the Company. Whenever required under this Section 1 to effect the
registration of any Registrable Securities, the Company shall, as expeditiously as reasonably
possible:

                    (a) prepare and file with the SEC a registration statement with respect to such Registrable
Securities and use all commercially reasonable efforts to cause such registration statement to
become effective, and, upon the request of the Holders of a majority of the Registrable Securities
registered thereunder, keep such registration statement effective for a period of up to ninety (90)
days or, if earlier, until the distribution contemplated in the Registration Statement has been
completed;

                    (b) prepare and file with the SEC such amendments and supplements to such registration
statement and the prospectus used in connection with such registration statement as may be
necessary to comply with the provisions of the Act with respect to the disposition of all
securities covered by such registration statement;

                    (c) furnish to the Holders such numbers of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Act,

7

 

and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable Securities owned by them;

                    (d) use all commercially reasonable efforts to register and qualify the securities covered by
such registration statement under such other securities or Blue Sky laws of such jurisdictions as
shall be reasonably requested by the Holders, provided that the Company shall not be required in
connection therewith or as a condition thereto to qualify to do business or to file a general
consent to service of process in any such states or jurisdictions;

                    (e) in the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing underwriter of such
offering;

                    (f) notify each Holder of Registrable Securities covered by such registration statement at any
time when a prospectus relating thereto is required to be delivered under the Act of the happening
of any event as a result of which the prospectus included in such registration statement, as then
in effect, includes an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances then existing;

                    (g) cause all such Registrable Securities registered pursuant to this Section 1 to be listed
on a national exchange or trading system and on each securities exchange and trading system on
which similar securities issued by the Company are then listed;

                    (h) provide a transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the
effective date of such registration;

                    (i) enter into such customary agreements, including but not limited to an underwriting
agreement, in usual and customary form, and take all such other actions as the holders of a
majority of the Registrable Securities being sold or the underwriters, if any, reasonably request
in order to expedite or facilitate the disposition of such Registrable Securities, including, but
not limited to, effecting a stock split or a combination of shares; and

                    (j) make available for inspection by any Holder of Registrable Securities or any underwriter
in the event of any underwritten public offering, and any attorney, accountant or other agent
retained by such Holder or underwriter, in each case upon receipt of a confidentiality agreement in
a form acceptable to the Company, all financial and other records, corporate documents and
properties of the Company, and shall use all commercially reasonable efforts to cause the Company’s
directors, officers, employees and independent accountants to
supply all such information reasonably requested by any Holder, underwriter, attorney,
accountant or agent in connection with the registration statement.

          Notwithstanding the provisions of this Section 1, the Company shall be entitled to postpone or
suspend, for a reasonable period of time, the filing, effectiveness or use of, or trading under,
any registration statement if the Company shall determine that any such filing or the sale of any
securities pursuant to such registration statement would:

8

 

                         (i) in the good faith judgment of the Board, materially impede, delay or interfere with any
material pending or proposed financing, acquisition, corporate reorganization or other similar
transaction involving the Company for which the Board has authorized negotiations;

                         (ii) in the good faith judgment of the Board, materially adversely impair the consummation of
any pending or proposed material offering or sale of any class of securities by the Company; or

                         (iii) in the good faith judgment of the Board, require disclosure of material nonpublic
information that, if disclosed at such time, would be materially harmful to the interests of the
Company and its stockholders; provided, however, that during any such period all
executive officers and directors of the Company are also prohibited from selling securities of the
Company (or any security of any of the Company’s subsidiaries or Affiliates).

     In the event of the suspension of effectiveness of any registration statement pursuant to this
Section 1.5, the applicable time period during which such registration statement is to remain
effective shall be extended by that number of days equal to the number of days during which the
effectiveness of such registration statement was suspended.

               1.6 Information from Holder. It shall be a condition precedent to the obligations of
the Company to take any action pursuant to this Section 1 with respect to the Registrable
Securities of any selling Holder that such Holder shall furnish to the Company such information
regarding itself, the Registrable Securities held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of such Holder’s
Registrable Securities.

               1.7 Expenses of Registration. All expenses other than underwriting discounts and
commissions incurred in connection with registrations, filings or qualifications pursuant to
Sections 1.2, 1.3 and 1.4, including (without limitation) all registration, filing and
qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the
Company and the reasonable fees and disbursements of (i) one counsel for the selling Holders other
than Intel Capital Corporation (“Intel Capital”) and its Affiliates (not to exceed $10,000)
and (ii) if Intel Capital is a selling Holder, one counsel for Intel Capital (not to exceed
$10,000), shall be borne by the Company. Notwithstanding the foregoing, the Company shall not be
required to pay for any expenses of any registration proceeding begun pursuant to Section 1.2 or
Section 1.4 if the registration request is subsequently withdrawn at the request of the Holders of
a majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses
pro rata based upon the number of Registrable Securities that were to be included in the withdrawn
registration), unless, in the case of a registration requested under Section 1.2 and 1.4, the
Holders of a majority of the Registrable Securities agree to forfeit their right to one demand
registration pursuant to Section 1.2 and 1.4 and provided, however, that if at the time of such
withdrawal, the Holders have learned of a material adverse change in the condition, business, or
prospects of the Company from that known to the Holders at the time of their request and have
withdrawn the request with reasonable promptness following disclosure by the Company of such
material adverse change, then the Holders shall not be required to pay any of such expenses and
shall retain their rights pursuant to Section 1.2 or 1.4. Notwithstanding

9

 

the foregoing, if the Company has already affected more than four (4) registrations pursuant to Section 1.4, then all
expenses incurred in connection with any additional registrations requested pursuant to Section
1.4, including (without limitation) all registration, filing, qualification, printer’s and
accounting fees and the reasonable fees and disbursements of counsel for the selling Holder or
Holders and counsel for the Company, shall be borne pro rata by the Holder or Holders participating
in the Form S-3 Registration.

               1.8 Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any such registration as the result of any controversy
that might arise with respect to the interpretation or implementation of this Section 1.

               1.9 Indemnification. In the event any Registrable Securities are included in a
registration statement under this Section 1:

                    (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder,
the partners, officers, directors and stockholders of each Holder, legal counsel and accountants
for each Holder, any underwriter (as defined in the Act) for such Holder and each person, if any,
who controls such Holder or underwriter within the meaning of the Act or the 1934 Act, against any
losses, claims, damages or liabilities (joint or several) to which they may become subject under
the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the
Act, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise
out of or are based upon any of the following statements, omissions or violations (collectively a
“Violation”): (i) any untrue statement or alleged untrue statement of a material fact
contained in such registration statement, including any preliminary prospectus or final prospectus
contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission
to state therein a material fact required to be stated therein, or necessary to make the statements
therein not misleading, or (iii) any violation or alleged violation by the Company of the Act, the
1934 Act, any state securities laws or any rule or regulation promulgated under the Act; the 1934
Act or any state securities laws, and the Company will reimburse each such Holder, underwriter,
controlling person or other aforementioned person for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss, claim, damage,
liability or action as such expenses are incurred; provided, however, that the indemnity agreement
contained in this subsection l.9(a) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent of the Company
(which consent shall not be unreasonably withheld), nor shall the Company be liable in any such
case for any such loss, claim, damage, liability or action to the extent that it arises out of or
is based upon a Violation that occurs in reliance upon and in conformity with written information
furnished expressly for use in connection with such registration by any such Holder, underwriter,
controlling person or other aforementioned person; provided further, however, that the foregoing
indemnity agreement with respect to any preliminary prospectus shall not inure to the benefit of
any Holder or underwriter or other aforementioned person, or any person controlling such Holder or
underwriter, from whom the person asserting any such losses, claims, damages or liabilities
purchased shares in the offering, if a copy of the most current prospectus was not sent or given by
or on behalf of such Holder or underwriter or other aforementioned person to such person, if
required by law so to have been delivered, at or prior to the written confirmation of the sale of

10

 

the shares to such person, and if the prospectus (as so amended or supplemented) would have cured
the defect giving rise to such loss, claim, damage or liability.

                    (b) To the extent permitted by law, each selling Holder will indemnify and hold harmless the
Company, each of its directors, each of its officers who has signed the registration statement,
each person, if any, who controls the Company within the meaning of the Act, legal counsel and
accountants for the Company, any underwriter, any other Holder selling securities in such
registration statement and any controlling person of any such underwriter or other Holder, against
any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons
may become subject, under the Act, the 1934 Act, any state securities laws or any rule or
regulation promulgated under the Act, the 1934 Act or any state securities laws, insofar as such
losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based
upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs
in reliance upon and in conformity with written information furnished by such Holder expressly for
use in connection with such registration; and each such Holder will reimburse any person intended
to be indemnified pursuant to this subsection l.9(b) for any legal or other expenses reasonably
incurred by such person in connection with investigating or defending any such loss, claim, damage,
liability or action as such expenses are incurred; provided, however, that the indemnity agreement
contained in this subsection l.9(b) shall not apply to amounts paid in settlement of any such loss,
claim, damage, liability or action if such settlement is effected without the consent of the Holder
(which consent shall not be unreasonably withheld), and provided that in no event shall any
indemnity under this subsection l.9(b) exceed the net proceeds from the offering received by such
Holder.

                    (c) Promptly after receipt by an indemnified party under this Section 1.9 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this Section 1.9,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying
party shall have the right to participate in and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually satisfactory to the parties; provided, however, that an indemnified party
(together with all other indemnified parties that may be represented without conflict by one
counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid
by the indemnifying party, if representation of
such indemnified party by the counsel retained by the indemnifying party would be
inappropriate due to actual or potential differing interests between such indemnified party and any
other party represented by such counsel in such proceeding. The failure to deliver written notice
to the indemnifying party within a reasonable time of the commencement of any such action, if
materially prejudicial to its ability to defend such action, shall relieve such indemnifying party
of liability to the indemnified party under this Section 1.9 to the extent of such prejudice, but
the omission so to deliver written notice to the indemnifying party will not relieve it of any
liability that it may have to any indemnified party otherwise than under this Section 1.9.

                    (d) If the indemnification provided for in this Section 1.9 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim,
damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such
indemnified party hereunder, shall contribute to the amount paid or

11

 

payable by such indemnified
party as a result of such loss, liability, claim, damage or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand and of the
indemnified party on the other in connection with the statements or omissions that resulted in such
loss, liability, claim, damage or expense, as well as any other relevant equitable considerations;
provided, however, that no contribution by any Holder, when combined with any amounts paid by such
Holder pursuant to Section 1.9(b), shall exceed the net proceeds from the offering received by such
Holder. The relative fault of the indemnifying party and of the indemnified party shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access
to information, and opportunity to correct or prevent such statement or omission.

                    (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the
underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control.

                    (f) The obligations of the Company and Holders under this Section 1.9 shall survive the
completion of any offering of Registrable Securities in a registration statement under this Section
1, and otherwise.

               1.10 Reports Under the 1934 Act. With a view to making available to the Holders the
benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a
Holder to sell securities of the Company to the public without registration or pursuant to a
registration on Form S-3, the Company agrees to:

                    (a) make and keep public information available, as those terms are understood and defined in
Rule 144, at all times after the effective date of the Initial Offering;

                    (b) file with the SEC in a timely manner all reports and other documents required of the
Company under the Act and the 1934 Act; and

                    (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith
upon request (i) a written statement by the Company that it has complied with the reporting
requirements of Rule 144 (at any time after ninety (90) days after the effective date of the first
registration statement filed by the Company), the Act and the 1934 Act (at any time after it has
become subject to such reporting requirements), or that it qualifies as a registrant whose
securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of
the most recent annual or quarterly report of the Company and such other reports and documents so
filed by the Company, and (iii) such other information as may be reasonably requested in availing
any Holder of any rule or regulation of the SEC that permits the selling of any such securities
without registration or pursuant to such form.

               1.11 Assignment of Registration Rights. The rights to cause the Company to register
Registrable Securities pursuant to this Section 1 may be assigned (but only

12

 

with all related obligations) by a Holder to a transferee or assignee of such securities that (i) is a subsidiary,
parent, partner, limited partner, retired partner, member, stockholder or Affiliate of a Holder,
(ii) is a Holder’s family member or trust for the benefit of an individual Holder, or (iii) after
such assignment or transfer, holds at least 200,000 shares of Registrable Securities (subject to
appropriate adjustment for stock splits, stock dividends, combinations and other
recapitalizations), provided: (a) the Company is, within a reasonable time after such transfer,
furnished with written notice of the name and address of such transferee or assignee and the
securities with respect to which such registration rights are being assigned; (b) such transferee
or assignee agrees in writing to be bound by and subject to the terms and conditions of this
Agreement, including, without limitation, the provisions of Section 1.13 below; and (c) such
assignment shall be effective only if immediately following such transfer the further disposition
of such securities by the transferee or assignee is restricted under the Act.

               1.12 Limitations on Subsequent Registration Rights. From and after the date of this
Agreement, the Company shall not, without the prior written consent of the Holders of a majority of
the Registrable Securities, enter into any agreement with any holder or prospective holder of any
securities of the Company that would allow such holder or prospective holder (a) to include such
securities in any registration filed under Section 1.2, Section 1.3 or Section 1.4 hereof, unless
under the terms of such agreement, such holder or prospective holder may include such securities in
any such registration only to the extent that the inclusion of such securities will not reduce the
amount of the Registrable Securities of the Holders that are included or (b) to demand registration
of their securities.

               1.13 “Market Stand-Off” Agreement. Each Holder hereby agrees that it will not,
without the prior written consent of the managing underwriter, during the period commencing on the
date of the final prospectus relating to the Company’s Initial Offering and ending on the date
specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (l80) days) (i) lend,
offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or
dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into
or exercisable or exchangeable for Common Stock held immediately prior to the effectiveness of the
Registration Statement for such offering, or (ii) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of the
Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled
by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing
provisions of this Section 1.13 shall apply only to the Company’s initial public offering of equity
securities, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting
agreement, and shall only be applicable to the Holders if all officers and directors and greater
than one percent (1%) stockholders of the Company enter into similar agreements. The underwriters
in connection with the Company’s Initial Offering are intended third party beneficiaries of this
Section 1.13 and shall have the right, power and authority to enforce the provisions hereof as
though they were a party hereto. Each Holder further agrees to execute such agreements as may be
reasonably requested by the underwriters in the Company’s Initial Offering that are consistent with
this Section 1.13 or that are necessary to give further effect thereto. Any discretionary waiver
or termination of the restrictions of any or all of such agreements by the Company or the
underwriters shall apply to

13

 

all Holders subject to such agreements pro rata based on the number of
shares subject to such agreements.

          In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions
with respect to the Registrable Securities of each Holder (and the shares or securities of every
other person subject to the foregoing restriction) until the end of such period.

               1.14 Termination of Registration Rights. No Holder shall be entitled to exercise any
right provided for in this Section 1 (i) after four (4) years following the consummation of the
Initial Offering or (ii) as to any Holder, such earlier time after the Initial Offering at which
such Holder (A) can sell all shares held by it in compliance with Rule 144(k) or (B) all
Registrable Securities held by such Holder (together with any Affiliate of the Holder with whom
such Holder must aggregate its sales under Rule 144) can be sold in any one (1)-month period
without registration in compliance with Rule 144.

          2. Covenants of the Company.

               2.1 Delivery of Financial Statements. The Company shall deliver to (i) each Investor
(or transferee of an Investor) for so long as there are at least 1,000,000 shares of Preferred
Stock issued and outstanding and (ii) to each individual Lender for so long as either the notes or
warrants issued to such Lender pursuant to the Lenders Agreement remain outstanding:

                    (a) as soon as practicable, but in any event within one hundred twenty (120) days after the
end of each fiscal year of the Company, an income statement for such fiscal year, a balance sheet
of the Company and statement of stockholders’ equity as of the end of such year, and a statement of
cash flows for such year, such year-end financial reports to be in reasonable detail, prepared in
accordance with generally accepted accounting principles, and audited and certified by independent
public accountants of nationally recognized standing selected by the Company;

                    (b) within thirty (30) days of the end of each month, an unaudited income statement and
statement of cash flows and balance sheet for and as of the end of such month, in reasonable
detail;

                    (c) as soon as practicable, but in any event at least thirty (30) days prior to the end of
each fiscal year, a budget and business plan for the next fiscal year, prepared on a monthly basis,
including balance sheets, income statements and statements of cash flows for such months and, as
soon as prepared, any other budgets or revised budgets prepared by the Company;

                    (d) such information, financial data and reports required by the Small Business Administration
or the New York State Certified Capital Program (“CAPCO”) in order for any Lender or
Investor to comply with applicable Small Business Investment Company or CAPCO regulations, as
applicable;

                    (e) copies of all material filings with governmental agencies and press releases promptly
after such filings or press releases are made; and

14

 

                    (f) such other information relating to the financial condition, business or corporate affairs
of the Company as any Lender or Investor may from time to time request, provided, however, that the
Company shall not be obligated under this subsection (f) or any other subsection of Section 2.1 to
provide information that it deems in good faith to be a trade secret or similar confidential
information, unless such Lender or Investor is already a party to a binding non-disclosure
agreement with the Company.

               2.2 Inspection. The Company shall permit each Investor, and each Lender whose note or
notes issued pursuant to the Lenders Agreement remain outstanding (each, a “Note Lender”),
at such party’s expense, to visit and inspect the Company’s properties, to examine its books of
account and records and to discuss the Company’s affairs, finances and accounts with its officers,
all at such reasonable times as may be requested by the Investor or Lender; provided,
however, that the Company shall not be obligated pursuant to this Section 2.2 to provide
access to any information that it reasonably considers to be a trade secret or similar confidential
information, unless such Lender or Investor is already a party to a binding non-disclosure
agreement with the Company.

               2.3 Termination of Information and Inspection Covenants . The covenants set forth in Sections 2.1 and 2.2 shall terminate and be of no further force
or effect when the sale of securities pursuant to a registration statement filed by the Company
under the Act in connection with the firm commitment underwritten offering of its securities to the
general public is consummated or when the Company first becomes subject to the periodic reporting
requirements of Sections 12(g) or 15(d) of the 1934 Act, whichever event shall first occur.

               2.4 Right of First Offer. Subject to the terms and conditions specified in this
Section 2.4, the Company hereby grants to each (i) Investor who holds at least 250,000 shares of
Preferred Stock, (ii) Note Lender who holds Lender Warrants exercisable for at least 250,000 shares
of Common Stock and (iii) Common Holder who holds at least 250,000 shares of Common Stock (each a
“Major Investor”) a right of first offer with respect to future sales by the Company of its
Shares (as hereinafter defined). For purposes of this Section 2.4, the term “Major
Investor” includes any general partners and Affiliates of a Major Investor. A Major Investor
shall be entitled to apportion the right of first offer hereby granted it among itself and its
partners and Affiliates in such proportions as it deems appropriate.

          Each time the Company proposes to offer any shares of, or securities of any type whatsoever
(including without limitation, options, warrants and convertible debt) that are or may become
convertible into or exchangeable or exercisable for any shares of, any class of its capital stock
whether common or preferred (“Shares”), the Company shall first make an offering of such
Shares to each Major Investor in accordance with the following provisions:

                    (a) The Company shall deliver a notice in accordance with Section 3.5 (“Notice”) to
the Major Investors stating (i) its bona fide intention to offer such Shares, (ii) the number of
such Shares to be offered, and (iii) the price and terms upon which it proposes to offer such
Shares.

                    (b) By written notification received by the Company within twenty (20) calendar days after
receipt of the Notice, each Major Investor may elect to purchase

15

 

or obtain, at the price and on the
terms specified in the Notice, up to that portion of such Shares that equals the proportion that
the number of shares of Registrable Securities issued and held by such Major Investor (assuming
full conversion and exercise of all convertible and exercisable Registrable Securities then
outstanding) bears to the total number of shares of Common Stock of the Company then outstanding
(assuming full conversion and exercise of all convertible and exercisable Registrable Securities
then outstanding).

                    (c) If all Shares that Major Investors are entitled to obtain pursuant to subsection 2.4(b)
are not elected to be obtained as provided in subsection 2.4(b) hereof, the Company may, during the
ninety (90) day period following the expiration of the period provided in subsection 2.4(b) hereof,
offer the remaining unsubscribed portion of such Shares to any person or persons at a price not
less than that, and upon terms no more favorable to the offeree than those, specified in the
Notice. If the Company does not enter into an agreement for the sale of the Shares within such
period, or if such agreement is not consummated within sixty (60) days of the execution thereof,
the right provided hereunder shall be deemed to be
revived and such Shares shall not be offered unless first reoffered to the Major Investors in
accordance herewith.

                    (d) The right of first offer in this Section 2.4 shall not be applicable to (i) the issuance
or sale of shares of Common Stock (or options therefor) to employees, directors, consultants and
other service providers for the primary purpose of soliciting or retaining their services pursuant
to stock plans or agreements approved by the Board; (ii) the issuance of securities pursuant to a
bona fide, firmly underwritten public offering of shares of Common Stock, registered under the Act,
(iii) the issuance of securities pursuant to the conversion or exercise of convertible or
exercisable securities including, without limitation, the conversion of interest pursuant to that
certain Note and Warrant Purchase Agreement dated November 18, 2002 and those certain promissory
notes issued in connection therewith, (iv) the issuance of securities in connection with a bona
fide business acquisition of the Company that constitutes a Liquidation Event (as defined in the
Company’s Fourth Amended and Restated Certificate of Incorporation, as amended (a “Liquidation
Event”)), whether by merger, consolidation, sale of assets, sale or exchange of stock or
otherwise, or the issuance of securities to sellers as purchase price in connection with
acquisitions of other entities, (v) the issuance and sale of Series C Preferred Stock pursuant to
the Series C Agreement, (vi) the issuance of stock, warrants or other securities or rights to
persons or entities with which the Company has business relationships, provided such issuances are
for other than primarily equity financing purposes and are approved by a majority of the Board or
(vii) the issuance of securities that, with unanimous approval of the Board, are not offered to any
existing stockholder of the Company. In addition to the foregoing, the right of first offer in
this Section 2.4 shall not be applicable with respect to any Major Investor and any subsequent
offering of Shares if (i) at the time of such offering, the Major Investor is not an “accredited
investor,” as that term is then defined in Rule 501(a) of the Act and (ii) such offering of Shares
is otherwise being offered only to accredited investors.

                    (e) The rights provided in this Section 2.4 may not be assigned or transferred by any Major
Investor; provided, however, that a Major Investor that is a venture capital fund
may assign or transfer such rights to an Affiliated venture capital fund.

16

 

                    (f) The covenants set forth in this Section 2.4 shall terminate and be of no further force or
effect upon the consummation of the sale of securities pursuant to a bona fide, firmly underwritten
public offering of shares of common stock registered under the Act.

               2.5 Key-Man Insurance. The Company shall maintain term life insurance on the lives of
certain key employees of the Company, as determined by the Board, in the amount of $1,000,000 each.
Such policies shall name the Company as loss payee and shall not be cancelable by the Company
without prior approval of the Board.

               2.6 Directors and Officers Insurance. The Company shall maintain in full force and
effect from financially sound and reputable insurers directors and officers commission and
liability insurance with coverage amounts determined by the Board of Directors. Such coverage amounts shall not be allowed to
lapse or be reduced without the prior approval of a majority of the directors elected by the
holders of Preferred Stock.

               2.7 Meetings of the Board of Directors. The Company will ensure that meetings of its
Board are held at least eight (8) times each year. The Company shall reimburse each director for
reasonable travel expenses incurred in connection with attending meetings or other functions of the
Board.

               2.8 Composition of Board Committees. The Company agrees to cause the Board to
establish or maintain a Compensation Committee and an Audit Committee. The Compensation Committee
shall consist of four (4) individuals and the Audit Committee shall consist of three (3)
individuals. Each of Crystal Internet Ventures, including Crystal Internet Venture Fund II (BVI),
L.P. and Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P. (collectively,
“Crystal”), Advantage Capital New York Partners I, L.P. (“Advantage”) and Pacven
Walden Ventures IV, L.P. (“Walden”) shall be entitled to nominate at least one (1)
representative to each such committee. North Atlantic Venture Fund III and North Atlantic SBIC IV,
L.P. (collectively, “North Atlantic”) shall be entitled to nominate at least one (1)
representative to the Compensation Committee. The right of Crystal, Advantage and Walden,
respectively, to nominate designees to the Compensation and Audit Committees and the right of North
Atlantic to nominate a designee to the Compensation Committee shall terminate upon the earlier of
(i) the date on which Crystal, Advantage, Walden or North Atlantic, as applicable, does not hold at
least fifteen percent (15%) of the shares of Common Stock initially issued to such Investor
(including those shares of Common Stock issued or issuable upon conversion of the Preferred Stock)
or (ii) approval by the Board of a transaction constituting a Liquidation Event.

               2.9 Confidentiality Agreement. The Company shall require all employees and
consultants with access to confidential information to execute and deliver a Confidentiality
Agreement in substantially the form approved by the Board.

               2.10 Termination of Certain Covenants. The covenants set forth in Sections 2.5, 2.6,
2.7 and 2.8 shall terminate and be of no further force or effect upon the consummation of the sale
of securities pursuant to a bona fide, firmly underwritten public offering of shares of common
stock registered under the Act.

17

 

               2.11 New Issuance and Liquidation Event. Without the prior written consent of Intel
Capital, the Company (i) shall not authorize or issue, or obligate itself to issue, or reclassify
any equity security (including any other security convertible into or exercisable for any such
equity security) having a preference over, or being on a parity with, the Company’s Series B
Preferred Stock, as designated in the Company’s Fourth Amended and Restated Certificate of
Incorporation, with respect to rights, preferences, privileges or restrictions, other than the good faith issuance of any authorized
but unissued shares of Preferred Stock (including any security convertible into or exercisable for
such shares of Preferred Stock) (for the avoidance of doubt, the shares issuable pursuant to that
certain Note and Warrant Purchase Agreement dated November 18, 2002 shall not require Intel
Capital’s consent pursuant to this Section 2.11) and (ii) shall not consummate a Liquidation Event.
Notwithstanding the prior sentence, the sale of shares of the Company’s Preferred Stock in a bona
fide financing transaction shall not be deemed a “Liquidation Event.” The covenants set forth in
this Section 2.11 shall terminate and be of no further force or effect upon the earlier to occur of
(i) the transfer by Intel Capital of its Shares to a transferee that is not a partner or Affiliate
of Intel Capital or (ii) the consummation of the sale of securities pursuant to an Initial
Offering.

          3. Miscellaneous.

               3.1 Successors and Assigns. Except as otherwise provided herein, the terms and
conditions of this Agreement shall inure to the benefit of and be binding upon the respective
successors and assigns of the parties (including transferees of any shares of Registrable
Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party
other than the parties hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as expressly provided in
this Agreement.

               3.2 Governing Law. This Agreement shall be governed by and construed under the laws
of the State of New York as applied to agreements among New York residents entered into and to be
performed entirely within New York.

               3.3 Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.

               3.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

               3.5 Notices. All notices and other communications given or made pursuant hereto shall
be in writing and shall be deemed effectively given: (i) upon personal delivery to the party to be
notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business
hours of the recipient; if not, then on the next business day, (iii) five (5) days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one
(1) day after deposit with a nationally recognized overnight courier, specifying next day delivery,
with written verification of receipt. All communications shall be

18

 

sent to the respective parties
at the addresses set forth on the signature pages attached hereto (or at such other addresses as
shall be specified by notice given in accordance with this Section 3.5).

               3.6 Expenses. If any action at law or in equity is necessary to enforce or interpret
the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees,
costs and necessary disbursements in addition to any other relief to which such party may be
entitled.

               3.7 Entire Agreement; Amendments and Waivers. This Agreement (including the Exhibits
hereto, if any) constitutes the full and entire understanding and agreement among the parties with
regard to the subjects hereof and thereof. Any term of this Agreement (other than Section 2.1,
Section 2.2, Section 2.3 and Section 2.4) may be amended and the observance of any term of this
Agreement may be waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the holders of a majority of the
Registrable Securities; provided that such majority shall include the consent of Intel
Capital until such time that Intel Capital transfers its Shares to a transferee that is not a
partner or Affiliate of Intel Capital; provided further, however, that in the event
that such amendment or waiver adversely affects the obligations and/or rights of the Common Holders
or Lenders in a different manner than the other Holders, such amendment or waiver shall also
require the written consent of the holders of a majority in interest of the Common Holders or
Lenders (as applicable). The provisions of Section 2.1 and Section 2.3 may be amended or waived
(either generally or in a particular instance and either retroactively or prospectively) only with
the written consent of the Company and the holders of a majority of the Registrable Securities that
are held by the qualifying Investors and Lenders. The provisions of Section 2.2 and Section 2.3
may be amended or waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the holders of a majority of the
Registrable Securities that are held by Investors and Note Lenders. The provisions of Section 2.4
may be amended or waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the holders of a majority of the
Registrable Securities held by Major Investors. Any amendment or waiver effected in accordance
with this paragraph shall be binding upon each holder of any Registrable Securities, each future
holder of all such Registrable Securities, and the Company.

               3.8 Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision(s) shall be excluded from this Agreement and the
balance of the Agreement shall be interpreted as if such provision(s) were so excluded and shall be
enforceable in accordance with its terms.

               3.9 Aggregation of Stock. All shares of Registrable Securities held or acquired by Affiliated Persons (including
Affiliated venture capital funds) shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement. The terms “Affiliate” and
“Affiliated” shall have the meanings set forth in the Series C Agreement.

               3.10 Binding Effect. In addition to any restriction or transfer that may be imposed
by any other agreement by which any Party hereto may be bound, this Agreement shall be binding upon
the Parties, their respective heirs, successors, transferees and assigns.

19

 

               3.11 Additional Investors. Notwithstanding Section 3.7, no consent or amendment shall
be necessary to add additional Investors as signatories to this Agreement, provided that such
Investors have purchased Series C Preferred Stock pursuant to the Series C Agreement. Schedule
A to this Agreement shall be updated to reflect such additional Investors.

               3.12 Arbitration. Any controversy between the parties hereto involving any claim
arising out of or relating to the termination of this Agreement, will be submitted to and be
settled by final and binding arbitration in New York, New York, in accordance with the then current
Commercial Arbitration Rules of the American Arbitration Association (the “AAA”), and
judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction
thereof; provided, however, that (i) this Section 3.12 shall not apply to Intel
Capital and its Affiliates and (ii) this Section 3.12 shall apply to any transferee of Shares that
is not a partner or Affiliate of Intel Capital. Such arbitration shall be conducted by three (3)
arbitrators chosen by the Company and the Holders, or failing such agreement, an arbitrator
experienced in the sale of similarly sized companies appointed by the AAA. There shall be limited
discovery prior to the arbitration hearing as follows: (a) exchange of witness lists and copies of
documentary evidence and documents relating to or arising out of the issues to be arbitrated, (b)
depositions of all party witnesses, and (c) such other depositions as may be allowed by the
arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the
New York Code of Civil Procedure, the arbitrator(s) shall be required to provide in writing to the
parties the basis for the award or order of such arbitrator(s), and a court reporter shall record
all hearings, with such record constituting the official transcript of such proceedings.

               3.13 Termination of Prior Agreement. Upon the effectiveness of this Agreement, the
Prior Agreement shall terminate and be of no further force and effect, and shall be superseded and
replaced in its entirety by this Agreement.

               3.14 Waiver of Right of First Refusal. In connection with the issuance and sale by
the Company of up to 2,740,407 shares of its Series C Preferred Stock pursuant to the Series C
Agreement (the “Series C  Financing”), the undersigned holders of a majority of the Registrable Securities held
by Major Investors of the Company (as such terms are defined in the Prior Agreement), on behalf of
themselves and all Major Investors, hereby unconditionally waive all rights of first offer and
notice set forth in Section 2.4 of the Prior Agreement with respect to the Series C Financing.

               3.15 Consent of Intel Capital. By executing this Agreement, Intel Capital hereby
consents to the Series C Financing (including without limitation the authorization and issuance of
the Series C Preferred Stock) pursuant to Section 2.11 of the Prior Agreement.

(Remainder of page intentionally left blank)

20

 

     IN WITNESS WHEREOF, the parties have executed this Second Amended and Restated Investors’
Rights Agreement as of the date first above written.

	 	 	 	 	 
	 
	 	 	COMPANY:
	 
	 	 	SYNACOR, INC.
	 
	 	 	 	 
	 

	 	By
	 	/s/ Ron Frankel
	 

	 	 	 	 
	 

	 	 	 	Ron Frankel
	 

	 	 	 	President
	 
	 	 	 	 
	Address:	 	40 La Riviere Drive, Suite 300
	 	 	Buffalo, NY 14202
	 
	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	INTEL CAPITAL CORPORATION
	 
	 	 	 	 
	 

	 	By
	 	/s/ James W. McCall
	 

	 	 	 	 
	 	 	Name: James W. McCall
	 	 	Title: Assistant Treasurer
	 
	 	 	 	 
	Address:	 	c/o Intel Corporation
	 	 	Attn: Intel Capital Portfolio Manager
	 	 	2200 Mission College Blvd., M/S RN6-46
	 	 	Santa Clara, CA 95052
	 	 	Facsimile: (408) 765-6038
	 
	 	 	 	 
	 	 	With a copy by e-mail to:
	 	 	portfolio.manager@intel.com
	 
	 	 	 	 
	 	 	SIGNATURE PAGE TO THE THIRD AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT BY AND AMONG SYNACOR,
INC. AND THE INVESTORS LISTED ON THE SIGNATURE PAGES
HERETO.

 Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	NORTH ATLANTIC VENTURE FUND III,
	 	 	a Limited Partnership
	 
	 	 	 	 
	 

	 	By:
	 	North Atlantic Investors III, LLC,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Mark J. Morrisette
	 

	 	 	 	 
	 	 	Name: Mark J. Morrisette
	 	 	Title: General Partner
	 
	 	 	 	 
	Address:	 	2 City Center
	 	 	 
	 	 	Portland, ME 04101
	 	 	 
	 
	 	 	 	 
	 	 	NORTH ATLANTIC SBIC IV, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	North Atlantic Investors SBIC IV, LLC,
	 

	 	 	 	its General Partner
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Mark J. Morrissette
	 

	 	 	 	 
	 	 	Name: Mark J. Morrissette
	 	 	Title: General Partner
	 
	 	 	 	 
	Address:	 	2 City Center
	 	 	 
	 	 	Portland, ME 04101
	 	 	 

 Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	MITSUI INCUBASE CORPORATION
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Yoshiaki Baba
	 

	 	 	 	 
	 	 	Name: Yoshiaki Baba
	 	 	Title: President & CEO
	 
	 	 	 	 
	Address:	 	20400 Stevens Creek Blvd. Suite 300
	 	 	 
	 	 	Cupertino, CA 95014
	 	 	 

Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	ADVANTAGE CAPITAL NEW YORK PARTNERS I, L.P.
	 
	 	 	 	 
	 	 	By: Advantage Capital New York GP-I, LLC, Its General

Partner
	 
	 	 	 	 
	 

	 	By
	 	/s/ M. Scott Murphy
	 

	 	 	 	 
	 

	 	 	 	M. Scott Murphy
	 

	 	 	 	Vice President
	 
	 	 	 	 
	Address:	 	5 Warren Street, Suite 204
	 	 	Glens Falls, NY 12801
	 
	 	 	 	 
	 	 	ADVANTAGE CAPITAL NEW YORK PARTNERS II, L.P.
	 
	 	 	 	 
	 	 	By: Advantage Capital New York GP-II, LLC, Its

General Partner
	 
	 	 	 	 
	 

	 	By
	 	/s/ M. Scott Murphy
	 

	 	 	 	 
	 

	 	 	 	M. Scott Murphy
	 

	 	 	 	Vice President
	 
	 	 	 	 
	Address:	 	5 Warren Street, Suite 204
	 	 	Glens Falls, NY 12801

Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS:
	 
	 	 	 	 
	 	 	ACCESS TECHNOLOGY CAPITAL, LLC
	 
	 	 	 	 
	 

	 	By
	 	/s/ Peter L. Thoren
	 

	 	 	 	 
	 	 	Name: Peter Thoren
	 	 	Title: Vice President
	 
	 	 	 	 
	Address:	 	730 Fifth Avenue, 20th Floor
	 	 	New York, NY 10019

Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS AND LENDERS:
	 
	 	 	 	 
	 	 	RAND CAPITAL SBIC, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Rand Capital Management, LLC,

its General Partner
	 
	 	 	 	 
	 

	 	By
	 	/s/ Dan Penberthy
	 

	 	 	 	 
	 	 	Name: Dan Penberthy
	 	 	Title: Manager
	 
	 	 	 	 
	Address:	 	2200 Rand Building
	 	 	Buffalo, NY 14203
	 
	 	 	 	 
	 	 	BUFFALO AND ERIE COUNTY INDUSTRIAL

LAND DEVELOPMENT CORPORATION
	 
	 	 	 	 
	 

	 	By
	 	/s/ Alfred D. Culliton
	 

	 	 	 	 
	 	 	Name: Alfred D. Culliton
	 	 	Title: CFO/CCO
	 
	 	 	 	 
	Address:	 	275 Oak Street
	 	 	Buffalo, NY 14203

Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS AND COMMON HOLDERS:
	 
	 	 	 	 
	 	 	CRYSTAL INTERNET VENTURE FUND II (BVI), L.P.
	 
	 	 	 	 
	 	 	CRYSTAL INTERNET VENTURE FUND II (BVI), CRYSTAL
VISION, L.P.
	 
	 	 	 	 
	 	 	By: Crystal Venture II, Ltd.
	 	 	Their: General Partner
	 
	 	 	 	 
	 

	 	By
	 	/s/ Joseph Tzeng
	 

	 	 	 	 
	 	 	Name: Joseph Tzeng
	 	 	Title: President
	 
	 	 	 	 
	Address:	 	1120 Chester Avenue, Suite 418
	 	 	Cleveland, OH 44114

Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS AND COMMON HOLDERS:
	 
	 	 	 	 
	 	 	/s/ Jeremy M. Jacobs, Jr.
	 	 	 
	 	 	Jeremy M. Jacobs, Jr.
	 
	 	 	 	 
	Address:	 	c/o Delaware North Co.
	 	 	40 Fountain Plaza
	 	 	Buffalo, NY 14202
	 	 	Attn: Mike Gallagher
	 
	 	 	 	 
	 	 	/s/ Jordon Levy
	 	 	 
	 	 	JoRon Management LLC
	 
	 	 	 	 
	Address:	 	50 Fountain Plaza
	 	 	Suite 1320
	 	 	Buffalo, NY 14202

 Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

	 	 	 	 	 
	 	 	INVESTORS AND COMMON HOLDERS:
	 
	 	 	 	 
	 	 	PACVEN WALDEN VENTURES IV ASSOCIATES FUND, L.P.
	 
	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan
	 

	 	 	 	 
	 	 	Name: Lip-Bu Tan
	 	 	Title: Director
	 
	 	 	 	 
	 	 	of Pacven Walden Management Co., Ltd.
	 	 	as General Partner of Pacven Walden Management II,
L.P.
	 	 	as General Partner of Pacven Walden Ventures IV
Associates Fund, L.P.
	 
	 	 	 	 
	 	 	PACVEN WALDEN VENTURES IV, L.P.
	 
	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan
	 

	 	 	 	 
	 	 	Name: Lip-Bu Tan
	 	 	Title: Director
	 
	 	 	 	 
	 	 	of Pacven Walden Management Co., Ltd.
	 	 	as General Partner of Pacven Walden Management II,
L.P.
	 	 	as General Partner of Pacven Walden Ventures IV, L.P.
	 
	 	 	 	 
	 	 	WIIG-TDF PARTNERS LLC
	 
	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan
	 

	 	 	 	 
	 	 	Name: Lip-Bu Tan
	 	 	Title: Director
	 
	 	 	 	 
	 	 	of WIIG Management Co., Ltd.
	 	 	for and on behalf of the Fund Managers
	 
	 	 	 	 
	 	 	WALDEN EDB PARTNERS II, L.P.
	 
	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan
	 

	 	 	 	 
	 	 	Name: Lip-Bu Tan
	 	 	Title: Director
	 
	 	 	 	 
	Address:	 	One California Street, Suite 2800
	 	 	San Francisco, CA 94111

 Signature page to Synacor, Inc.

Third Amended and Restated Investors’ Rights Agreement

 

 

SCHEDULE A

LIST OF SERIES C INVESTORS

Access Technology Capital, LLC

Advantage Capital New York Partners I, L.P.

Advantage Capital New York Partners II, L.P.

Crystal Internet Venture Fund II (BVI), L.P.

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

Intel Capital Corporation

JoRon Management LLC

Jeremy M. Jacobs, Jr.

Mitsui Incubase Corporation

North Atlantic SBIC IV, L.P.

North Atlantic Venture Fund III

Rand Capital SBIC, L.P.

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

Walden EDB Partners II, L.P.

WIIG-TDF Partners LLC

 

 

SCHEDULE B

LIST OF SERIES B INVESTORS

Access Technology Capital, LLC

Advantage Capital New York Partners I, L.P.

Crystal Internet Venture Fund II (BVI), L.P.

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

Intel Capital Corporation

Jeremy M. Jacobs, Jr.

JoRon Management LLC

Rand Capital SBIC, L.P.

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

 

 

SCHEDULE C

LIST OF SERIES A-1 INVESTORS

Advantage Capital New York Partners I, L.P.

 

 

SCHEDULE D

LIST OF SERIES A INVESTORS

Crystal Internet Venture Fund II (BVI), Ltd.

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

JoRon Management LLC

Jeremy M. Jacobs, Jr.

Joseph J. Castiglia

Robert G. Weber

Fors Family Limited Partnership

Paul J. Harder

Stephen A. Nappo

Steven R. Kieffer

David M. Carroll

John Lally

Kevin Cornacchio

Charles Kelkenberg

David T. Hore

Robert Santa Maria

Herbert J. Heimerl, Jr.

Guy Berberich

Thomas F. Hanlon III

Paul Wiepert

Scott M. McCarthy

Samuel LaNasa

Chek Ventures LLC

Chek Ventures II LLC

Chek Ventures III LLC

Intel Capital Corporation

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

WIIG-TDF Partners LLC

Walden EDB Partners II, L.P.

Access Technology Capital, LLC

Mike Nappo

Don Wehrung

Sean Hus Var

Richard Lally

Kenneth Lally

Rand Capital SBIC, L.P.

Buffalo and Erie County Industrial Land Development Corporation

 

 

SCHEDULE E

LIST OF COMMON HOLDERS

@Visory LLC

Charles A. Anken & Sandra S. Olivieri

Gabriel Adiv

Darren Ascone

Frederick G. Attea

Dennis Ball

Ed Bujanowski

Malcolm Burnett

Ronald B. Cadby

Angelo J. Cammilleri

Rebecca Cammilleri

Michael Campanella

Barak Carmon

Blake Carver

George Chamoun

Chek Ventures LLC

Chek Ventures II LLC

Henry Cole

Kari Cole

Mike Collins

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

Crystal Internet Venture Fund II (BVI), Ltd.

Larry Decker

Deeridge Investment Partnership

Anthony Diina

Tracy Fernandez

First Albany Corporation

Douglas Fish

Garage.com Investments I, L.P.

Garage Securities, Inc.

Michael Garofalo

Keith Gizzi

Drew Graham

Leota Knapp Hair

George Harris

Jesper Henriksen

Sean Hus Var

ICE Family Partnership

Janet Ingalsbe

Innovasia Venture Partners I Limited (BVI)

Jeremy M. Jacobs, Sr.

Jeremy M. Jacobs, Jr.

 

 

Craig W. Johnson

JoRon Management LLC

Rick Keisic

Rachel K. King

Kyle Kokanovich

Kandice Kraus

Ted Leiser

Brian Lipke

Brad Loftin

Mary K. Mahley

Randolph Marks

Kenneth McCreadie

John F. McMahon

Mary G. McMahon

Daniel J. Neaverth, Jr.

David Michael Neaverth

Darren Anthony Neaverth

Dean James Neaverth

Rory B. O’Connor

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

Sunita S. Pandit

Virginia R. Piotrowski

Ron Poole

Michael Prince

Brad Pritchard

ProSeed Capital Holdings CVA

Santi Rao

Redwood Management III LP

Redwood Ventures III LP

Danielle Restaino

Aimee Richardson

Howard Schomer

Cindy Schwartz

Phil Seibel

Francine Seifert

Gur Shomron

The Sidne J. Long Trust u/a/d 4-26-84

SMB Investment Partnership

Mike Snusz

Sarah Sorensen

Joseph Spychalski

Tom Stanton

David Stempkowski

The Sternheim Trust

Dave Tucker

 

 

Patti Strauss

VLG Investments 1998

Walden EDB Partners II LP

Linda Wancyzk

Robert Weiner

Alison Wentker

WIIG-TDF Partners LLC

Raymond Young

Gregory Zaepfel

 

 

SCHEDULE F

LIST OF LENDERS

Rand Capital SBIC, L.P.

Buffalo and Erie County Industrial Land Development CorporationEX-4.4

 

EXHIBIT
4.4

THIRD AMENDED AND RESTATED

STOCK RESTRICTION, FIRST REFUSAL AND CO-SALE AGREEMENT

          This THIRD AMENDED AND RESTATED STOCK RESTRICTION, FIRST REFUSAL AND CO-SALE AGREEMENT (the
“Agreement”) is made and entered into as of October 19, 2006, by and among Synacor, Inc., a
Delaware corporation (the “Company”), the holders of Series C Preferred Stock of the
Company (the “Series C Preferred Stock”) listed on the Schedule of Series C Investors
attached as Schedule A hereto (the “Series C Investors”), the holders of Series B
Preferred Stock of the Company (the “Series B Preferred Stock”) listed on the Schedule of
Series B Investors attached as Schedule B hereto (the “Series B Investors”), the
holders of Series A-1 Preferred Stock of the Company (the “Series A-1 Preferred Stock”)
listed on the Schedule of Series A-1 Investors attached as Schedule C hereto (the
“Series A-1 Investors”), the holders of Series A Preferred Stock of the Company (the
“Series A Preferred Stock” and, together with the Series C Preferred Stock, the Series B
Preferred Stock and the Series A-1 Preferred Stock, the “Preferred Stock”) listed on the
Schedule of Series A Investors attached as Schedule D hereto (the “Series A
Investors” and, together with the Series C Investors, the Series B Investors and the Series A-1
Investors, the “Investors”) and the holders of Common Stock of the Company (the “Common
Stock”) or warrants to purchase Common Stock of the Company (collectively, the “Common
Holders”) listed on the Schedule of Common Holders attached as Schedule E hereto. The
Company, the Common Holders and the Investors are individually each referred to herein as a
“Party” and are collectively referred to herein as the “Parties.” The Company’s
Board of Directors is referred to herein as the “Board.”

WITNESSETH:

          WHEREAS, the Company and the Series C Investors have entered into that certain Series C
Preferred Stock Purchase Agreement of even date herewith (the “Purchase Agreement”), which
provides for, among other things, the purchase by the Series C Investors of shares of Series C
Preferred Stock;

          WHEREAS, the execution and delivery of this Agreement is a condition to the closing of the
transactions contemplated by the Purchase Agreement;

          WHEREAS, the Company, certain of the Investors and the Common Holders are parties to that
certain Second Amended and Restated Stock Restriction, First Refusal and Co-Sale Agreement dated as
of October 1, 2004 (the “Prior Agreement”);

          WHEREAS, Section 10 of the Prior Agreement provides that the Prior Agreement may be amended
only with the written consent of the Company and Investors (as defined therein) holding at least
two thirds of the Common Stock (as defined therein) issued or issuable upon conversion of the
Preferred Stock (as defined therein), such majority to include the consent of Intel Capital
Corporation; and

          WHEREAS, the parties to the Prior Agreement necessary to amend such Prior Agreement have
resolved to do so, and such parties hereby agree that this Agreement shall

 

 

amend and restate the Prior Agreement in its entirety and to accept the rights created
pursuant hereto in lieu of the rights created under the Prior Agreement;

          NOW, THEREFORE, in consideration of the foregoing premises and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as
follows:

          1. Definitions.

               (a) Affiliate. For purposes of this Agreement, the terms “Affiliate” and
“Affiliated” shall have the meanings set forth in the Purchase Agreement.

               (b) Delivery. For purposes of this Agreement, the term “Delivery” shall have
the meaning set forth in Section 6 below.

               (c) Equity Securities. For purposes of this Agreement, the term “Equity
Securities” shall mean (i) any shares of Common Stock, or options or warrants exercisable for
Common Stock, now or hereafter owned or held by a Common Holder or an Investor (or a transferee in
accordance with Section 2.4 herein), (ii) any shares of Preferred Stock now or hereafter owned or
held by a Common Holder or an Investor (or a transferee in accordance with Section 2.4 herein) or
(iii) shares of any series of preferred stock created after the date hereof and securities of any
type whatsoever that are, or may become, convertible into or exchangeable into or exercisable for
shares of Common Stock or Preferred Stock.

               (d) Holders. For purposes of this Agreement, the term “Holders” shall mean
the Investors or persons who have acquired shares from any of such persons or their transferees or
assignees in accordance with the provisions of this Agreement.

               (e) Transfer. For purposes of this Agreement, the term “Transfer” shall
include any sale, assignment, encumbrance, hypothecation, pledge, conveyance in trust, gift,
transfer by bequest, devise or descent, or other transfer or disposition of any kind, including,
but not limited to, transfers pursuant to divorce or legal separation, transfers to receivers,
levying creditors, trustees or receivers in bankruptcy proceedings or general assignees for the
benefit of creditors, whether voluntary, involuntarily or by operation of law, directly or
indirectly, of any of the Equity Securities.

               (f) Release Date. For the purposes of this Agreement, the term “Release Date”
shall mean November 18, 2007.

          2. Agreements Among the Company, the Investors and the Common Holders.

          2.1 Rights of First Refusal.

               (a) Transfer Notice. If at any time a Common Holder or Investor proposes to Transfer
Equity Securities (a “Selling Stockholder”), then the Selling Stockholder shall promptly
give the Company written notice of the Selling Stockholder’s intention to make the Transfer (the
“Transfer Notice”). The Transfer Notice shall include (i) a description of the

2

 

Equity Securities to be transferred (the “Offered Shares”), (ii) the name(s) and
address(es) of the prospective transferee(s), (iii) the consideration to be paid and (iv) the
material terms and conditions upon which the proposed Transfer is to be made. The Company shall
promptly forward the Transfer Notice to each Holder. The Transfer Notice shall certify that the
Selling Stockholder has received a firm offer from the prospective transferee(s) and in good faith
believes a binding agreement for the Transfer is obtainable on the terms set forth in the Transfer
Notice. The Transfer Notice shall also include a copy of any written proposal, term sheet or
letter of intent or other agreement relating to the proposed Transfer. In the event that the
Transfer is being made pursuant to the provisions of Section 2.4, the Transfer Notice shall state
under which specific subsection the Transfer is being made.

               (b) Company’s Right of First Refusal. The Company shall have an option for a period
of ten (10) days from Delivery of the Transfer Notice to elect to purchase the Offered Shares at
the same price and subject to the same material terms and conditions as described in the Transfer
Notice. The Company may exercise such purchase option and purchase all or any portion of the
Offered Shares by notifying the Selling Stockholder in writing before expiration of such ten (10)
day period as to the number of such shares that it wishes to purchase. If the Company gives the
Selling Stockholder notice that it desires to purchase such shares, then payment for the Offered
Shares shall be by check or wire transfer, against delivery of the Offered Shares to be purchased
at a place agreed upon between the parties and at the time of the scheduled closing therefor, which
shall be no later than forty-five (45) days after Delivery to the Company of the Transfer Notice,
unless the Transfer Notice contemplated a later closing with the prospective third-party
transferee(s) or unless the value of the purchase price has not yet been established pursuant to
Section 2.1(e). If the Company fails to purchase any or all of the Offered Shares by exercising
the option granted in this Section 2.1(b) within the period provided, the remaining Offered Shares
shall be subject to the options granted to the Holders pursuant to subsection 2.1(d).

               (c) Additional Transfer Notice. Subject to the Company’s option set forth in Section
2.1(b), if at any time the Selling Stockholder proposes a Transfer, then, within five (5) days
after the Company has declined to purchase all, or a portion, of the Offered Shares or the
Company’s option to so purchase the Offered Shares has expired, the Selling Stockholder shall give
each Holder an “Additional Transfer Notice” that shall include all of the information and
certifications required in a Transfer Notice and shall additionally identify the Offered Shares
that the Company has declined to purchase (the “Remaining Shares”) and briefly describe the
Holders’ rights of first refusal and co-sale rights with respect to the proposed Transfer.

               (d) Holder’s Right of First Refusal.

                    (i) Each Holder shall have an option for a period of fifteen (15) days from Delivery of the
Additional Transfer Notice from the Selling Stockholder set forth in Section 2.1(c) to elect to
purchase its pro rata share of the Remaining Shares at the same price and subject to the same
material terms and conditions as described in the Additional Transfer Notice. Each Holder may
exercise such purchase option and thereby purchase all or any portion of his, her or its respective
pro rata shares (with any re-allotments as provided below) of the Remaining Shares (a
“Participating Holder”) by notifying the Selling Stockholder in writing, before the
expiration of the fifteen (15) day period, as to the number of such shares which he, she

3

 

or it wishes to purchase (including any re-allotment). Each Holder’s pro rata share of the
Remaining Shares shall be a fraction of the Remaining Shares, of which the number of shares of
Preferred Stock owned by such Holder on the date of the Transfer Notice shall be the numerator and
the total number of shares of Preferred Stock held by all Holders on the date of the Transfer
Notice shall be the denominator. Each Holder shall have a right of re-allotment such that, if any
other Holder fails to exercise the right to purchase its full pro rata share of the Remaining
Shares, the Fully Participating Holders (as defined below) may exercise an additional right to
purchase, on a pro rata basis, the Remaining Shares not previously purchased.

                    (ii) In the event any Holder elects not to purchase its pro rata share of the Remaining Shares
available pursuant to its option under subsection 2.1(d)(i) within the time period set forth
therein, then the Selling Stockholder shall promptly give written notice (the “Overallotment
Notice”) to each Participating Holder that has elected to purchase all of its pro rata share of
the Remaining Shares (each a “Fully Participating Holder”), which notice shall set forth
the number of Remaining Shares not purchased by the other Holders, and shall offer the Fully
Participating Holders the right to acquire such unsubscribed shares. Each Fully Participating
Holder shall have five (5) days after Delivery of the Overallotment Notice to deliver a written
notice to the Selling Stockholder (the “Participating Holders Overallotment Notice”) of its
election to purchase its pro rata share of the unsubscribed shares on the same terms and conditions
as set forth in the Additional Transfer Notice and indicating the maximum number of the
unsubscribed shares that it will purchase in the event that any other Fully Participating Holder
elects not to purchase its pro rata share of the unsubscribed shares. For purposes of this
subsection 2.1(d)(ii), the numerator shall be the same as that used in subsection 2.1(d)(i) above
and the denominator shall be the total number of shares of Preferred Stock owned by all Fully
Participating Holders on the date of the Transfer Notice. Each Participating Holder shall be
entitled to apportion the Remaining Shares to be purchased among its partners and Affiliates
(including, in the case of a venture capital fund, other venture capital funds Affiliated with such
fund), provided that such Participating Holder notifies the Selling Stockholder of each such
allocation.

               (e) Payment.

                    (i) The Participating Holders shall effect the purchase of the Offered Shares with payment by
check or wire transfer, against delivery of the Offered Shares to be purchased at a place agreed
upon between the parties and at the time of the scheduled closing therefor, which shall be no later
than forty-five (45) days after Delivery to the Company of the Transfer Notice, unless the Transfer
Notice contemplated a later closing with the prospective third-party transferee(s) or unless the
value of the purchase price has not yet been established pursuant to this subsection 2.1(e).

                    (ii) Should the purchase price specified in the Transfer Notice or Additional Transfer Notice
be payable in property other than cash or evidences of indebtedness, the Company (and the
Participating Holders) shall have the right to pay the purchase price in the form of cash equal in
amount to the fair market value of such property. If the Selling Stockholder and the Company (or
the Participating Holders) cannot agree on such fair market value within ten (10) days after
Delivery to the Company of the Transfer Notice (or the Delivery of the Additional Transfer Notice
to the Holders), the valuation shall be made by an

4

 

appraiser of recognized standing selected by the Selling Stockholder and the Company (or the
Participating Holders) or, if they cannot agree on an appraiser within twenty (20) days after
Delivery to the Company of the Transfer Notice (or the Delivery of the Additional Transfer Notice
to the Holders), each shall select an appraiser of recognized standing and those appraisers shall
designate a third appraiser of recognized standing, whose appraisal shall be determinative of such
value. The cost of such appraisal shall be shared equally by the Selling Stockholder and the
Company (and the Participating Holders), with half of the cost borne by the Company and the
Participating Holders pro rata by each, based on the number of shares such parties have expressed
an interest in purchasing pursuant to this Section 2. If the time for the closing of the Company’s
purchase or the Participating Holders’ purchase has expired but the determination of the value of
the purchase price offered by the prospective transferee(s) has not been finalized, then such
closing shall be held on or prior to the fifth business day after such valuation shall have been
made pursuant to this subsection.

          2.2 Right of Co-Sale.

               (a) To the extent the Company and the Holders do not exercise their respective rights of first
refusal as to all of the Offered Shares or the Remaining Shares pursuant to Section 2.1, then each
Holder (a “Selling Holder” for purposes of this Section 2.2) that notifies the Selling
Stockholder in writing within twenty (20) days after Delivery of the Transfer Notice referred to in
subsection 2.1(c), shall have the right to participate in such sale of Equity Securities on the
same terms and conditions as specified in the Transfer Notice. Such Selling Holder’s notice to the
Selling Stockholder shall indicate the number of shares of capital stock of the Company that the
Selling Holder wishes to sell under his, her or its right to participate. To the extent one or
more of the Holders exercise such right of participation in accordance with the terms and
conditions set forth below, the number of shares of Equity Securities that the Selling Stockholder
may sell in the Transfer shall be correspondingly reduced.

               (b) Each Selling Holder may sell all or any part of that number of shares of capital stock of
the Company equal to the product obtained by multiplying (i) the aggregate number of shares of
Equity Securities covered by the Transfer Notice that have not been subscribed for pursuant to
Section 2.1 by (ii) a fraction, the numerator of which is the number of shares of Preferred Stock
owned by the Selling Holder on the date of the Transfer Notice and the denominator of which is the
total number of Equity Securities owned by the Selling Stockholder and all of the Selling Holders
on the date of the Transfer Notice.

               (c) Each Selling Holder shall effect its participation in the sale by promptly delivering to
the Selling Stockholder for transfer to the prospective purchaser one or more certificates,
properly endorsed for transfer, which represent:

                    (i) the type and number of shares of capital stock of the Company that such Selling Holder
elects to sell; or

                    (ii) that number of shares of capital stock of the Company that are at such time convertible
into the number of shares of Common Stock that such Selling Holder elects to sell;
provided, however, that if the prospective third-party purchaser objects to the
delivery of shares of capital stock of the Company in lieu of Common Stock, such Selling Holder

5

 

shall convert such shares of capital stock of the Company into Common Stock and deliver Common
Stock as provided in this Section 2.2. The Company agrees to make any such conversion concurrent
with the actual transfer of such shares to the purchaser and contingent on such transfer.

               (d) The stock certificate or certificates that the Selling Holder delivers to the Selling
Stockholder pursuant to subsection 2.2(c) shall be transferred to the prospective purchaser in
consummation of the sale of the Equity Securities pursuant to the terms and conditions specified in
the Transfer Notice, and the Selling Stockholder shall concurrently therewith remit to such Selling
Holder that portion of the sale proceeds to which such Selling Holder is entitled by reason of its
participation in such sale. To the extent that any prospective purchaser or purchasers prohibits
such assignment or otherwise refuses to purchase shares or other securities from a Selling Holder
exercising its rights of co-sale hereunder, the Selling Stockholder shall not sell to such
prospective purchaser or purchasers any Equity Securities unless and until, simultaneously with
such sale, the Selling Stockholder shall purchase such shares or other securities from such Selling
Holder for the same consideration and on the same terms and conditions as the proposed transfer
described in the Transfer Notice.

          2.3 Non-Exercise of Rights. To the extent that the Company and the Holders have not
exercised their rights to purchase the Offered Shares or the Remaining Shares within the time
periods specified in Section 2.1 and the Holders have not exercised their rights to participate in
the sale of the Remaining Shares within the time periods specified in Section 2.2, the Selling
Stockholder shall have a period of thirty (30) days from the expiration of such rights in which to
sell the Offered Shares or the Remaining Shares, as the case may be, upon terms and conditions
(including the purchase price) no more favorable than those specified in the Transfer Notice, to
the third-party transferee(s) identified in the Transfer Notice. The third-party transferee(s)
shall acquire the Offered Shares and the Remaining Shares free and clear of subsequent rights of
first refusal and co-sale rights under this Agreement. In the event the Selling Stockholder does
not consummate the sale or disposition of the Offered Shares and Remaining Shares within the thirty
(30) day period from the expiration of these rights, the Company’s first refusal rights and the
Holders’ first refusal rights and co-sale rights shall continue to be applicable to any subsequent
disposition of the Offered Shares or the Remaining Shares by the Selling Stockholder until such
right lapses in accordance with the terms of this Agreement. Furthermore, the exercise or
non-exercise of the rights of the Company and the Holders under this Section 2 to purchase Equity
Securities from the Selling Stockholder or participate in sales of Equity Securities by the Selling
Stockholder shall not adversely affect their rights to make subsequent purchases from the Selling
Stockholder of Equity Securities or subsequently participate in sales of Equity Securities by the
Selling Stockholder.

          2.4 Limitations of Rights of First Refusal and Co-Sale. Notwithstanding the
provisions of Section 2.1 and 2.2 of this Agreement, the first refusal rights of the Company and
the first refusal rights and co-sale rights of the Holders shall not apply to (a) the Transfer of
Equity Securities to any spouse or member of the Common Holder’s or Investor’s immediate family, or
to a custodian, trustee (including a trustee of a voting trust), executor, or other fiduciary for
the account of the Common Holder’s or Investor’s spouse or members of the Common Holder’s or
Investor’s immediate family, or to a trust for the Common Holder’s or Investor’s own self, or a
charitable remainder trust, (b) any Transfer between an entity and its

6

 

partners and Affiliates (including, in the case of a venture capital fund, other venture
capital funds Affiliated with such fund), (c) any sale of Equity Securities to the public pursuant
to a registration statement filed with, and declared effective by, the Securities and Exchange
Commission under the Securities Act of 1933, as amended or (d) the Transfer of any Equity
Securities owned or otherwise held by Intel Capital Corporation (“Intel Capital”) or its
Affiliates; provided, however, that in the event of any transfer made pursuant to
one of the exemptions provided by clauses (a), (b), (c) or (d), (i) the Common Holder or Investor
shall inform the Investors of such Transfer prior to effecting it and (ii) each such transferee or
assignee, prior to the completion of the Transfer, shall have executed documents assuming the
obligations of the Common Holder or Investor under this Agreement with respect to the transferred
Equity Securities. Such transferred Equity Securities shall remain “Equity Securities”
hereunder, and such pledgee, transferee or donee shall be treated as the “Common Holder or
Investor” for purposes of this Agreement.

          2.5 Prohibited Transfers.

               (a) Except as otherwise provided in this Agreement, each Common Holder and Investor will not
sell, assign, transfer, pledge, hypothecate or otherwise encumber or dispose of in any way, all of
any part of or any interest in the Equity Securities. Any sale, assignment, transfer, pledge,
hypothecation or other encumbrance or disposition of Equity Securities not made in conformance with
this Agreement shall be null and void, shall not be recorded on the books of the Company and shall
not be recognized by the Company.

               (b) In the event the Common Holder or Investor should sell any Equity Securities in
contravention of the co-sale rights of the Holders under Section 2.2 (a “Prohibited
Transfer”), the Holders, in addition to such other remedies as may be available at law, in
equity or hereunder, shall have the put option provided below under subsection (c), and the Common
Holder and Investor shall be bound by the applicable provisions of such option.

               (c) In the event of a Prohibited Transfer, each Holder shall have the right to sell to the
Common Holder and Investor the type and number of shares of Equity Securities equal to the number
of shares each Holder would have been entitled to transfer to the third-party transferee(s) under
Section 2.2 hereof had the Prohibited Transfer been effected pursuant to and in compliance with the
terms hereof. Such sale shall be made on the following terms and conditions:

                    (i) The price per share at which the shares are to be sold to the Common Holder and Investor
shall be equal to the price per share paid by the third-party transferee(s) to the Common Holder
and Investor in the Prohibited Transfer. The Common Holder and Investor shall also reimburse each
Holder for any and all fees and expenses, including legal fees and expenses, incurred pursuant to
the exercise or the attempted exercise of the Holder’s rights under Section 2.2.

                    (ii) Within ninety (90) days after the later of the date on which the Holder (A) receives
notice of the Prohibited Transfer or (B) otherwise becomes aware of the Prohibited Transfer, each
Holder shall, if exercising the option created hereby, deliver to the

7

 

Common Holder and Investor the certificate or certificates representing shares to be sold,
each certificate to be properly endorsed for transfer.

                    (iii) The Common Holder and Investor shall, upon receipt of the certificate or certificates
for the shares to be sold by a Holder pursuant to this Section 2.5, pay the aggregate purchase
price therefor and the amount of reimbursable fees and expenses, as specified in subsection
2.5(c)(i), in cash or by other means acceptable to the Holder.

               (d) Except as provided in Sections 2.4 and 2.6 hereof, no Common Holder or Investor shall
transfer shares of Common Stock, or options or warrants exerciseable for shares of Common Stock,
until the Release Date. Following the Release Date all Transfers of shares of Common Stock, or
options or warrants exercisable for shares of Common Stock, shall be subject to the first refusal
rights of the Company and the first refusal and co-sale rights of the Holders set forth in Sections
2.1 and 2.2 hereof.

          2.6 Mandatory Offer to Sell.

               (a) In the event that any Common Holder (i) dies or otherwise ceases to exist, (ii) is
declared incompetent by a court of competent jurisdiction, (iii) files a petition (or a petition is
filed against such Common Holder) for relief under applicable bankruptcy or insolvency law, and
such petition is not dismissed within sixty (60) days of filing, (iv) is dissolved or liquidated,
(v) effects a transfer for the benefit of creditors of such Common Holder generally, or (vi) is
obligated to transfer any shares of Common Stock of the Company in connection with a divorce or
dissolution, or is party to any property settlement or separation agreement wherein shares of
Common Stock of the Company are awarded the former or separated spouse or domestic partner of such
Common Holder who is not already a stockholder of the Company (each of subsections 2.6(a)(i)
through (vi) shall be referred to herein as a “Triggering Event”), then all shares of
Common Stock held by such Common Holder, or a transferee in accordance with Section 2.4 herein,
shall be deemed to be offered for sale to the Company at a price per share determined pursuant to
subsection 2.6(b) below; provided, however, that this Section 2.6 shall not apply
to (A) in the event such Common Holder dies, those shares of Common Stock held by such Common
Holder that would otherwise be transferred pursuant to Section 2.4 hereof, (B) in the event that a
Common Holder is declared incompetent, those shares of Common Stock held by such Common Holder that
can be voted by a transferee in accordance with Section 2.4 hereof, and (C) in connection with a
divorce or separation, those shares of Common Stock not transferred in connection therewith.

               (b) With respect to any shares of Common Stock to be transferred pursuant to Section 2.6(a)
above the purchase price per share shall determined by an appraiser of recognized standing selected
by the Board. The Company shall notify such Common Holder, or the permitted transferee thereof, of
the purchase price so determined within thirty (30) days after receipt by the Company of written
notice of any Triggering Event.

               (c) The right of the Company to purchase any shares of Common Stock pursuant to this Section
2.6 may be assigned by the Board, in whole or in part, to the Investors, on a pro rata basis, or to
other stockholders of the Company if no Investor elects to accept such assignment.

8

 

          3. Assignments and Transfers; No Third-Party Beneficiaries. This Agreement and the
rights and obligations of the Parties hereunder shall inure to the benefit of, and be binding upon,
their respective successors, assigns and legal representatives, but shall not otherwise be for the
benefit of any third party. The rights of the Holders hereunder are only assignable (i) to any
other Holder or (ii) to a partner or Affiliate of such Holder; provided that except as otherwise
provided in Section 2, each Common Holder and Investor will not sell, assign, transfer, pledge,
hypothecate or otherwise encumber or dispose of in any way, all of any part of or any interest in
the Equity Securities.

          4. Legend. Each existing or replacement certificate for the Company’s shares now
owned or hereafter acquired shall bear the following legend upon its face:

“THE SALE, PLEDGE, HYPOTHECATION, ASSIGNMENT OR TRANSFER OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN
STOCK RESTRICTION, FIRST REFUSAL AND CO-SALE AGREEMENT BY AND AMONG THE STOCKHOLDER,
THE CORPORATION AND CERTAIN HOLDERS OF STOCK OF THE CORPORATION. COPIES OF SUCH
AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.”

          5. Effect of Change in Company’s Capital Structure. If, from time to time, the
Company pays a stock dividend or effects a stock split or other change in the character or amount
of any of the outstanding stock of the Company, then in such event any and all new, substituted or
additional securities to which the Common Holder and Investor is entitled by reason of such Common
Holder’s and Investor’s ownership of Equity Securities shall be immediately subject to the rights
and obligations set forth in this Agreement with the same force and effect as the stock subject to
such rights immediately before such event.

          6. Notices. All notices and other communications given or made pursuant hereto shall
be in writing and shall be deemed effectively given: (i) upon personal delivery to the party to be
notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business
hours of the recipient; if not, then on the next business day, (iii) five (5) days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one
(1) business day after deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt. The occurrence of the events set forth in
subsections (i) through (iv) above shall constitute “Delivery” of notice. All
communications shall be sent to the respective parties at the addresses set forth on the signature
pages attached hereto (or at such other addresses as shall be specified by notice given in
accordance with this Section 6).

          7. Further Instruments and Actions. The Parties agree to execute such further
instruments and to take such further action as may reasonably be necessary to carry out the intent
of this Agreement. Each Common Holder and Investor agrees to cooperate affirmatively with the
Company, and to the extent reasonably requested by the Company, the Holders, to enforce rights and
obligations pursuant hereto.

9

 

          8. Term. This Agreement shall terminate and be of no further force or effect upon the
earliest to occur of (a) the consummation of the Company’s sale of its Common Stock or other
securities pursuant to a registration statement on Form S-1 or Form SB-2 under the Securities Act
of 1933, as amended, the aggregate proceeds of which is not less than $25,000,000 or (b) the
consummation of a Liquidation Event, as that term is defined in the Company’s Fourth Amended and
Restated Certificate of Incorporation (as amended from time to time).

          9. Entire Agreement. This Agreement contains the entire understanding of the parties
hereto with respect to the subject matter hereof and supersedes all other agreements between or
among any of the parties with respect to the subject matter hereof. This Agreement shall be
interpreted under the laws of the State of New York without reference to New York conflicts of law
provisions. The Prior Agreement is hereby amended and restated in its entirety and shall be of no
further force or effect.

          10. Amendments and Waivers. This Agreement may be terminated, any term of this
Agreement may be amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or prospectively) only with the
written consent of (i) the Company, and (ii) Investors holding at least two thirds of the Common
Stock issuable or issued upon conversion of the Preferred Stock; provided, however,
that such majority shall include the consent of Intel Capital until such time that Intel Capital
transfers its Shares to a transferee that is not a partner or Affiliate of Intel Capital;
provided further, however, that in the event such termination, amendment or waiver
adversely affects the rights and/or obligations of the Common Holders in a different manner than
the Holders, such termination, amendment or waiver shall also require the written consent of the
holders of at least a majority of the Common Stock then held by the Common Holders. Any amendment
or waiver effected in accordance with this paragraph shall be binding upon each Party and their
respective successors and assigns.

          11. Severability. If one or more provisions of this Agreement is held to be
unenforceable under applicable law, such provision shall be excluded from this Agreement and the
balance of the Agreement shall be interpreted as if such provision were so excluded and shall be
enforceable in accordance with its terms.

          12. Attorney’s Fees. In the event that any dispute among the parties to this
Agreement should result in litigation, the prevailing party in such dispute shall be entitled to
recover from the losing party all fees, costs and expenses of enforcing any right of such
prevailing party under or with respect to this Agreement, including without limitation, such
reasonable fees and expenses of attorneys and accountants, which shall include, without limitation,
all fees, costs and expenses of appeals.

          13. Aggregation of Stock. For the purposes of determining the availability of any
rights under this Agreement, the holdings of any transferee and assignee of an individual or a
partnership who is a spouse, ancestor, lineal descendant or siblings of such individual or partners
or retired partners of such partnership or Affiliates of such partnership (including spouses and
ancestors, lineal descendants and siblings of such partners or spouses who acquire Common Stock by
gift, will or intestate succession) shall be aggregated together with the individual or

10

 

partnership, as the case may be, for the purpose of exercising any rights or taking any action
under this Agreement. In addition, all holdings of Affiliates shall be aggregated together for the
purpose of determining the availability of any rights under this Agreement.

          14. Binding Effect. In addition to any restriction or transfer that may be imposed by
any other agreement by which any Party hereto may be bound, this Agreement shall be binding upon
the Parties, their respective heirs, successors, transferees and assigns.

          15. Additional Investors. Notwithstanding Section 10 hereof, no consent shall be
necessary to (i) add additional Investors as signatories to this Agreement, provided that
such Investors have purchased shares of Series C Preferred Stock pursuant to the Purchase Agreement
or received Equity Securities pursuant to Section 2.4 hereof or (ii) add additional Common Holders
as signatories to this Agreement. The Company shall not issue Common Stock to any Person if,
immediately after the issuance of such Common Stock (or if such Common Stock is issued upon
conversion or exercise of another security convertible into, or exercisable for, such Common Stock,
immediately after the issuance of such other security), such Person would hold more than one
percent (1%) of the Company’s Common Stock (assuming the conversion of all outstanding Preferred
Stock and the exercise of all outstanding warrants and options), unless (a) such Person becomes a
signatory to this Agreement, (b) such Common Stock is otherwise subject to a right of first refusal
in favor of the Company (including a right of first refusal under stock option or stock purchase
plans or agreements used in connection therewith) or (c) Investors holding at least a majority of
the Common Stock issued or issuable upon conversion of the Preferred Stock otherwise consent in
writing. The schedules to this Agreement shall be updated to reflect such additional Investors and
Common Holders.

          16. Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.

(Remainder of page intentionally left blank)

11

 

          IN WITNESS WHEREOF, the parties hereto have executed this Third Amended and Restated Stock
Restriction, First Refusal and Co-Sale Agreement as of the date first written above.

	 	 	 	 	 	 	 
	 	 	COMPANY:	 	 
	 
	 	 	 	 	 	 
	 	 	SYNACOR, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Ron Frankel
 

Ron Frankel
	 	 
	 

	 	 	 	President	 	 
	 
	 	 	 	 	 	 
	Address:	 	40 La Riviere Drive, Suite 300

Buffalo, NY 14202	 	 
	 
	 	 	 	 	 	 
	 	 	INVESTORS:	 	 
	 
	 	 	 	 	 	 
	 	 	INTEL CAPITAL CORPORATION	 	 
	 

	 	By
	 	/s/ James W. McCall
 

	 	 
	 	 	Name: James W. McCall

Title: Assistant Treasurer	 	 
	 
	 	 	 	 	 	 
	Address:	 	c/o Intel Corporation

Attn: Intel Capital Portfolio Manager

2200 Mission College Blvd., M/S RN6-46

Santa Clara, CA 95052

Facsimile: (408) 765-6038

With a copy by e-mail to:

portfolio.manager@intel.com	 	 
	 
	 	 	 	 	 	 
	 	 	SIGNATURE PAGE TO THE THIRD AMENDED AND
RESTATED STOCK RESTRICTION, FIRST REFUSAL AND
CO-SALE AGREEMENT BY AND AMONG SYNACOR, INC. AND
THE INVESTORS LISTED ON THE SIGNATURE PAGES
HERETO.	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 	 	 
	 	 	INVESTORS:	 	 
	 
	 	 	 	 	 	 
	 	 	NORTH ATLANTIC VENTURE FUND III,

a Limited Partnership	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	North Atlantic Investors III, LLC,	 	 
	 

	 	 	 	its General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Mark J. Morrissette
 

	 	 
	 	 	Name: Mark J. Morrissette

Title: General Partner	 	 
	 
	 	 	 	 	 	 
	Address:	 	2 City Center

Portland, ME 04101	 	 
	 
	 	 	 	 	 	 
	 	 	NORTH ATLANTIC SBIC IV, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	North Atlantic Investors SBIC IV, LLC,	 	 
	 

	 	 	 	its General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Mark J. Morrissette
 

	 	 
	 	 	Name: Mark J. Morrissette

Title: General Partner	 	 
	 
	 	 	 	 	 	 
	Address:	 	2 City Center

Portland, ME 04101	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 	 	 
	 	 	INVESTORS:	 	 
	 
	 	 	 	 	 	 
	 	 	MITSUI INCUBASE CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Yoshiaki Baba
 

	 	 
	 	 	Name: Yoshiaki Baba

Title: President & CEO	 	 
	 
	 	 	 	 	 	 
	Address:	 	20400 Stevens Creek Blvd. Suite 300

Cupertino, CA 95014	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 	 	 
	 	 	INVESTORS:	 	 
	 
	 	 	 	 	 	 
	 	 	ADVANTAGE CAPITAL NEW YORK 
PARTNERS I, L.P.	 	 
	 

	 	By:
	 	Advantage Capital New York GP-I, LLC,	 	 
	 

	 	 	 	Its General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ M. Scott Murphy
 

M. Scott Murphy

Vice President
	 	 
	 
	 	 	 	 	 	 
	Address:	 	5 Warren Street, Suite 204

Glens Falls, NY 12801	 	 
	 
	 	 	 	 	 	 
	 	 	ADVANTAGE CAPITAL NEW YORK 
PARTNERS II, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	Advantage Capital New York GP-II,	 	 
	 

	 	 	 	LLC, Its General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ M. Scott Murphy
 

M. Scott Murphy

Vice President
	 	 
	 
	 	 	 	 	 	 
	Address:	 	5 Warren Street, Suite 204

Glens Falls, NY 12801	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 	 	 
	 	 	INVESTORS:	 	 
	 
	 	 	 	 	 	 
	 	 	ACCESS TECHNOLOGY CAPITAL, LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Peter L. Thoren
 

	 	 
	 	 	Name: Peter Thoren

Title: Vice President	 	 
	 
	 	 	 	 	 	 
	Address:	 	730 Fifth Avenue, 20th Floor

New York, NY 10019	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 	 	 
	 	 	INVESTORS AND COMMON STOCK

WARRANT HOLDERS:	 	 
	 
	 	 	 	 	 	 
	 	 	RAND CAPITAL SBIC, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	Rand Capital Management, LLC,

its General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Dan Penberthy
 

	 	 
	 	 	Name: Dan Penberthy

Title: Manager	 	 
	 
	 	 	 	 	 	 
	Address:	 	2200 Rand Building

Buffalo, NY 14203	 	 
	 
	 	 	 	 	 	 
	 	 	BUFFALO AND ERIE COUNTY

INDUSTRIAL LAND DEVELOPMENT

CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Alfred D. Culliton
 

	 	 
	 	 	Name: Alfred D. Culliton

Title: CFO/CLO	 	 
	 
	 	 	 	 	 	 
	Address:	 	275 Oak Street

Buffalo, NY 14203	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 	 	 
	 	 	INVESTORS AND COMMON HOLDERS:	 	 
	 
	 	 	 	 	 	 
	 	 	CRYSTAL INTERNET VENTURE FUND II
 (BVI), L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	CRYSTAL INTERNET VENTURE FUND II

(BVI), CRYSTAL VISION, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	Crystal Venture II, Ltd.	 	 
	 	 	Their: General Partner	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Joseph Tzeng
 

	 	 
	 	 	Name: Joseph Tzeng

Title: President	 	 
	 
	 	 	 	 	 	 
	Address:	 	1120 Chester Avenue, Suite 418

Cleveland, OH 44114	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 
	 

	 	INVESTORS AND COMMON HOLDERS:	 	 
	 
	 	 	 	 
	 

	 	/s/ Jeremy M. Jacobs, Jr.
 

Jeremy M. Jacobs, Jr.
	 	 
	 
	 	 	 	 
	Address:

	 	c/o Delaware North Co.

40 Fountain Plaza

Buffalo, NY 14202

Attn: Mike Gallagher	 	 
	 
	 	 	 	 
	 

	 	/s/ Jordon Levy	 	 
	 

	 	 	 	 
	 

	 	JoRon Management LLC	 	 
	 
	 	 	 	 
	Address:

	 	50 Fountain Plaza

Suite 1320

Buffalo, NY 14202	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 	 	 
	 	 	INVESTORS AND COMMON HOLDERS:	 	 
	 
	 	 	 	 	 	 
	 	 	PACVEN WALDEN VENTURES IV
 ASSOCIATES FUND, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan
 

	 	 
	 	 	Name: Lip-Bu Tan

Title: Director	 	 
	 
	 	 	 	 	 	 
	 	 	of Pacven Walden Management Co., Ltd. 

as General Partner of Pacven Walden Management II, L.P.

as General Partner of Pacven Walden Ventures IV

Associates Fund, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	PACVEN WALDEN VENTURES IV, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan
 

	 	 
	 	 	Name: Lip-Bu Tan

Title: Director	 	 
	 
	 	 	 	 	 	 
	 	 	of Pacven Walden Management Co., Ltd.

as General Partner of Pacven Walden Management II, L.P.

as General Partner of Pacven Walden Ventures IV, L.P.	 	 
	 
	 	 	 	 	 	 
	 	 	WIIG-TDF PARTNERS LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Lip-Bu Tan

Title: Director	 	 
	 
	 	 	 	 	 	 
	 	 	of WIIG Management Co., Ltd.

for and on behalf of the Fund Managers	 	 
	 
	 	 	 	 	 	 
	 	 	WALDEN EDB PARTNERS II, L.P.	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	/s/ Lip-Bu Tan	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Lip-Bu Tan

Title: Director	 	 
	 
	 	 	 	 	 	 
	 	 	Address:    One California Street, Suite 2800

                    San Francisco, CA 94111	 	 

Signature Page to Synacor, Inc.

Third Amended and Restated Stock Restriction,

First Refusal and Co-Sale Agreement

 

 

Schedule A

Schedule of Series C Investors

Access Technology Capital, LLC

Advantage Capital New York Partners I, L.P.

Advantage Capital New York Partners II, L.P.

Crystal Internet Venture Fund II (BVI), L.P.

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

Intel Capital Corporation

JoRon Management LLC

Jeremy M. Jacobs, Jr.

Mitsui Incubase Corporation

North Atlantic SBIC IV, L.P.

North Atlantic Venture Fund III, a Limited Partnership

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

Rand Capital SBIC, L.P.

WIIG-TDF Partners LLC

Walden EDB Partners II, L.P.

 

 

Schedule B

Schedule of Series B Investors

Access Technology Capital, LLC

Advantage Capital New York Partners I, L.P.

Crystal Internet Venture Fund II (BVI), L.P.

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

Intel Capital Corporation

Jeremy M. Jacobs, Jr.

JoRon Management LLC

Rand Capital SBIC, L.P.

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

 

 

Schedule C

Schedule of Series A-1 Investors

Advantage Capital New York Partners I, L.P.

 

 

Schedule D

Schedule of Series A Investors

Crystal Internet Venture Fund II (BVI), Ltd.

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

JoRon Management LLC

Jeremy M. Jacobs, Jr.

Joseph J. Castiglia

Robert G. Weber

Fors Family Limited Partnership

Paul J. Harder

Stephen A. Nappo

Steven R. Kieffer

David M. Carroll

John Lally

Kevin Cornacchio

Charles Kelkenberg

David T. Hore

Robert Santa Maria

Herbert J. Heimerl, Jr.

Guy Berberich

Thomas F. Hanlon III

Paul Wiepert

Scott M. McCarthy

Samuel LaNasa

Chek Ventures LLC

Chek Ventures II LLC

Chek Ventures III LLC

Intel Capital Corporation

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

WIIG-TDF Partners LLC

Walden EDB Partners II, L.P.

Access Technology Capital, LLC

Mike Nappo

Don Wehrung

Sean Hus Var

Richard Lally

Kenneth Lally

Rand Capital SBIC, L.P.

Buffalo and Erie County Industrial Land Development Corporation

 

 

Schedule E

Common Holders

@Visory LLC

Charles A. Anken & Sandra S. Olivieri

Gabriel Adiv

Darren Ascone

Frederick G. Attea

Dennis Ball

Ed Bujanowski

Malcolm Burnett

Ronald B. Cadby

Angelo J. Cammilleri

Rebecca Cammilleri

Michael Campanella

Barak Carmon

Blake Carver

George Chamoun

Chek Ventures LLC

Chek Ventures II LLC

Henry Cole

Kari Cole

Mike Collins

Crystal Internet Venture Fund II (BVI), Crystal Vision, L.P.

Crystal Internet Venture Fund II (BVI), Ltd.

Larry Decker

Deeridge Investment Partnership

Anthony Diina

Tracy Fernandez

First Albany Corporation

Douglas Fish

Garage.com Investments I, L.P.

Garage Securities, Inc.

Michael Garofalo

Keith Gizzi

Drew Graham

Leota Knapp Hair

George Harris

Jesper Henriksen

Sean Hus Var

ICE Family Partnership

Janet Ingalsbe

Innovasia Venture Partners I Limited (BVI)

Jeremy M. Jacobs, Sr.

Jeremy M. Jacobs, Jr.

 

 

Craig W. Johnson

JoRon Management LLC

Rick Keisic

Rachel K. King

Kyle Kokanovich

Kandice Kraus

Ted Leiser

Brian Lipke

Brad Loftin

Mary K. Mahley

Randolph Marks

Kenneth McCreadie

John F. McMahon

Mary G. McMahon

Daniel J. Neaverth, Jr.

David Michael Neaverth

Darren Anthony Neaverth

Dean James Neaverth

Rory B. O’Connor

Pacven Walden Ventures IV Associates Fund, L.P.

Pacven Walden Ventures IV, L.P.

Sunita S. Pandit

Virginia R. Piotrowski

Ron Poole

Michael Prince

Brad Pritchard

ProSeed Capital Holdings CVA

Santi Rao

Redwood Management III LP

Redwood Ventures III LP

Danielle Restaino

Aimee Richardson

Howard Schomer

Cindy Schwartz

Phil Seibel

Francine Seifert

Gur Shomron

The Sidne J. Long Trust u/a/d 4-26-84

SMB Investment Partnership

Mike Snusz

Sarah Sorensen

Joseph Spychalski

Tom Stanton

David Stempkowski

The Sternheim Trust

Dave Tucker

 

 

Patti Strauss

VLG Investments 1998

Walden EDB Partners II LP

Linda Wancyzk

Robert Weiner

Alison Wentker

WIIG-TDF Partners LLC

Raymond Young

Gregory Zaepfel

Common Stock Warrant Holders

Rand Capital SBIC, L.P.

Buffalo and Erie County Industrial Land Development Corporation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]